10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________________________________ 

FORM 10-Q

______________________________________ 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2021

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 000-32191

______________________________________ 

T. ROWE PRICE GROUP, INC.

(Exact name of registrant as specified in its charter)

Maryland	52-2264646
(State of incorporation)	(I.R.S. Employer Identification No.)

100 East Pratt Street, Baltimore, Maryland 21202

(Address, including Zip Code, of principal executive offices)

(410) 345-2000

(Registrant’s telephone number, including area code)

________________

Common stock, $.20 par value per share	TROW	The NASDAQ Stock Market LLC
(title of security)	(ticker symbol)	(Name of exchange on which registered)

______________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 of the Securities Exchange Act of 1934 during the preceding 12 months, and (2) has been subject to such filing requirements for the past 90 days.    ☒  Yes    ☐  No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months.    ☒  Yes    ☐  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer (do not check if smaller reporting company)	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐  Yes    ☒  No

The number of shares outstanding of the issuer’s common stock ($.20 par value), as of the latest practicable date,

April 27, 2021, is 226,855,575.

The exhibit index is at Item 6 on page 34.

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions, except share data)

	3/31/2021		12/31/2020
ASSETS
Cash and cash equivalents	$	2,830.1	$	2,151.7
Accounts receivable and accrued revenue	885.9		863.1
Investments	3,403.6		3,250.8
Assets of consolidated T. Rowe Price investment products ($1,782.9 million at March 31, 2021 and $2,497.4 million at December 31, 2020, related to variable interest entities)	1,946.8		2,695.5
Operating lease assets	110.2		117.6
Property and equipment, net	703.9		695.4
Goodwill	665.7		665.7
Other assets	218.2		219.2
Total assets	$	10,764.4	$	10,659.0
LIABILITIES
Accounts payable and accrued expenses	$	228.9	$	187.7
Liabilities of consolidated T. Rowe Price investment products ($49.0 million at March 31, 2021 and $47.7 million at December 31, 2020, related to variable interest entities)	53.7		57.7
Operating lease liabilities	146.0		154.1
Accrued compensation and related costs	260.8		133.6
Supplemental savings plan liability	769.9		772.2
Income taxes payable	284.0		85.0
Total liabilities	1,743.3		1,390.3
Commitments and contingent liabilities
Redeemable non-controlling interests	1,012.9		1,561.7
STOCKHOLDERS’ EQUITY
Preferred stock, undesignated, $.20 par value – authorized and unissued 20,000,000 shares	—		—
Common stock, $.20 par value—authorized 750,000,000; issued 226,948,000 shares at March 31, 2021 and 227,965,000 at December 31, 2020	45.4		45.6
Additional capital in excess of par value	654.6		654.6
Retained earnings	7,338.7		7,029.8
Accumulated other comprehensive loss	(30.5)		(23.0)
Total permanent stockholders’ equity	8,008.2		7,707.0
Total liabilities, redeemable non-controlling interests, and permanent stockholders’ equity	$	10,764.4	$	10,659.0

The accompanying notes are an integral part of these statements.

Page 2

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(in millions, except per-share amounts)

	Three months ended
	3/31/2021		3/31/2020
Revenues
Investment advisory fees	$	1,687.8	$	1,327.8
Administrative, distribution, and servicing fees	139.0		134.8
Net revenues	1,826.8		1,462.6
Operating expenses
Compensation and related costs	583.5		440.7
Distribution and servicing	85.6		65.7
Advertising and promotion	18.9		24.9
Product-related costs	41.0		41.6
Technology, occupancy, and facility costs	117.3		105.4
General, administrative, and other	87.3		77.1
Total operating expenses	933.6		755.4
Net operating income	893.2		707.2
Non-operating income (loss)
Net gains (losses) on investments	68.6		(154.6)
Net gains (losses) on consolidated investment products	37.2		(330.3)
Other income (loss)	(3.7)		(15.4)
Total non-operating income (loss)	102.1		(500.3)
Income before income taxes	995.3		206.9
Provision for income taxes	230.5		40.3
Net income	764.8		166.6
Less: net income (loss) attributable to redeemable non-controlling interests	15.4		(176.5)
Net income attributable to T. Rowe Price Group	$	749.4	$	343.1
Earnings per share on common stock of T. Rowe Price Group
Basic	$	3.20	$	1.43
Diluted	$	3.17	$	1.41

The accompanying notes are an integral part of these statements.

Page 3

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in millions)

	Three months ended
	3/31/2021		3/31/2020
Net income	$	764.8	$	166.6
Other comprehensive income (loss)
Currency translation adjustments
Consolidated T. Rowe Price investment products - variable interest entities	(18.9)		(25.1)
Reclassification gains recognized in non-operating income upon deconsolidation of certain T. Rowe Price investment products	(2.6)		(.1)
Total currency translation adjustments of consolidated T. Rowe Price investment products - variable interest entities	(21.5)		(25.2)
Equity method investments	(.8)		(.1)
Other comprehensive loss before income taxes	(22.3)		(25.3)
Net deferred tax benefits	3.0		2.0
Total other comprehensive loss	(19.3)		(23.3)
Total comprehensive income	745.5		143.3
Less: comprehensive income (loss) attributable to redeemable non-controlling interests	3.6		(193.7)
Total comprehensive income attributable to T. Rowe Price Group	$	741.9	$	337.0

The accompanying notes are an integral part of these statements.

Page 4

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)

	Three months ended
	3/31/2021		3/31/2020
Cash flows from operating activities
Net income	$	764.8	$	166.6
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization of property and equipment	49.0		46.1
Stock-based compensation expense	57.5		58.3
Net (gains) losses recognized on investments	(59.5)		167.3
Net change in T. Rowe Price investment products used to economically hedge supplemental savings plan liability	22.0		(8.9)
Net change in securities held by consolidated T. Rowe Price investment products	(120.9)		234.6
Other changes in assets and liabilities	281.8		123.7
Net cash provided by operating activities	994.7		787.7
Cash flows from investing activities
Purchases of T. Rowe Price investment products	(12.5)		(225.1)
Dispositions of T. Rowe Price investment products	60.3		299.1
Net cash of T. Rowe Price investment products on deconsolidation	(27.3)		(.8)
Additions to property and equipment	(58.8)		(46.0)
Other investing activity	7.5		.4
Net cash (used in) provided by investing activities	(30.8)		27.6
Cash flows from financing activities
Repurchases of common stock	(259.2)		(891.3)
Common share issuances under stock-based compensation plans	20.9		38.1
Dividends paid to common stockholders of T. Rowe Price Group	(252.3)		(215.2)
Net subscriptions received from redeemable non-controlling interest holders	183.1		76.1
Net cash used in financing activities	(307.5)		(992.3)
Effect of exchange rate changes on cash and cash equivalents of consolidated T. Rowe Price investment products	.9		(1.2)
Net change in cash and cash equivalents during period	657.3		(178.2)
Cash and cash equivalents at beginning of period, including $104.8 million at December 31, 2020, and $76.5 million at December 31, 2019, held by consolidated T. Rowe Price investment products	2,256.5		1,858.3
Cash and cash equivalents at end of period, including $83.7 million at March 31, 2021, and $117.7 million at March 31, 2020, held by consolidated T. Rowe Price investment products	$	2,913.8	$	1,680.1

The accompanying notes are an integral part of these statements.

Page 5

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(shares in thousands; dollars in millions)

	Three months ended 3/31/2021
	Common shares outstanding	Common stock		Additional capital in excess of par value		Retained earnings		AOCI(1)		Total stockholders’ equity		Redeemable non-controlling interests
Balances at December 31, 2020	227,965	$	45.6	$	654.6	$	7,029.8	$	(23.0)	$	7,707.0	$	1,561.7
Net income	—	—		—		749.4		—		749.4		15.4
Other comprehensive income (loss), net of tax	—	—		—		—		(7.5)		(7.5)		(11.8)
Dividends declared ($1.08 per share)	—	—		—		(252.3)		—		(252.3)		—
Shares issued upon option exercises	572	.1		25.3		—		—		25.4		—
Net shares issued upon vesting of restricted stock units	41	—		(3.7)		—		—		(3.7)		—
Stock-based compensation expense	—	—		57.5		—		—		57.5		—
Restricted stock units issued as dividend equivalents	—	—		.1		(.1)		—		—		—
Common shares repurchased	(1,630)	(.3)		(79.2)		(188.1)		—		(267.6)		—
Net subscriptions into T. Rowe Price investment products	—	—		—		—		—		—		187.5
Net deconsolidations of T. Rowe Price investment products	—	—		—		—		—		—		(739.9)
Balances at March 31, 2021	226,948	$	45.4	$	654.6	$	7,338.7	$	(30.5)	$	8,008.2	$	1,012.9
	Three months ended 3/31/2020
	Common shares outstanding	Common stock		Additional capital in excess of par value		Retained earnings		AOCI(1)		Total stockholders’ equity		Redeemable non-controlling interests
Balances at December 31, 2019	235,214	$	47.0	$	654.6	$	6,443.5	$	(43.0)	$	7,102.1	$	1,121.0
Net income	—	—		—		343.1		—		343.1		(176.5)
Other comprehensive income (loss), net of tax	—	—		—		—		(6.1)		(6.1)		(17.2)
Dividends declared ($0.90 per share)	—	—		—		(214.7)		—		(214.7)		—
Shares issued upon option exercises	1,068	.2		41.1		—		—		41.3		—
Net shares issued upon vesting of restricted stock units	37	—		(3.0)		—		—		(3.0)		—
Stock-based compensation expense	—	—		58.3		—		—		58.3		—
Restricted stock units issued as dividend equivalents	—	—		.1		(.1)		—		—		—
Common shares repurchased	(8,334)	(1.6)		(96.5)		(788.9)		—		(887.0)		—
Net subscriptions into T. Rowe Price investment products	—	—		—		—		—		—		63.8
Net deconsolidations of T. Rowe Price investment products	—	—		—		—		—		—		(20.1)
Balances at March 31, 2020	227,985	$	45.6	$	654.6	$	5,782.9	$	(49.1)	$	6,434.0	$	971.0

(1) Accumulated other comprehensive income.

The accompanying notes are an integral part of these statements.

Page 6

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 – THE COMPANY AND BASIS OF PREPARATION.

T. Rowe Price Group Inc. derives its consolidated revenues and net income primarily from investment advisory services that its subsidiaries provide to individual and institutional investors in the T. Rowe Price U.S. mutual funds (“U.S. mutual funds”), subadvised funds, separately managed accounts, collective investment trusts, and other

T. Rowe Price products. The other T. Rowe Price products include open-ended investment products offered to investors outside the U.S., and products offered through variable annuity life insurance plans in the U.S. We also provide certain investment advisory clients with related administrative services, including distribution, mutual fund transfer agent, accounting, and shareholder services; participant recordkeeping and transfer agent services for defined contribution retirement plans; brokerage; trust services; and non-discretionary advisory services through model delivery.

Investment advisory revenues depend largely on the total value and composition of assets under our management. Accordingly, fluctuations in financial markets and in the composition of assets under management impact our revenues and results of operations.

BASIS OF PRESENTATION.

These unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States. These principles require the use of estimates and reflect all adjustments that are, in the opinion of management, necessary for a fair statement of our results for the interim periods presented. All such adjustments are of a normal recurring nature. Actual results may vary from our estimates. Certain prior year amounts have been reclassified to conform to the 2021 presentation.

The unaudited interim financial information contained in these unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements contained in our 2020 Annual Report.

NEWLY ISSUED BUT NOT YET ADOPTED ACCOUNTING GUIDANCE

We have considered all newly issued accounting guidance that is applicable to our operations and the preparation of our unaudited condensed consolidated statements, including those we have not yet adopted. We do not believe that any such guidance has or will have a material effect on our financial position or results of operations.

NOTE 2 – INFORMATION ABOUT RECEIVABLES, REVENUES, AND SERVICES.

Revenues earned under agreements with clients include: 

	Three months ended 3/31/2021								Three months ended 3/31/2020
			Administrative, distribution, and servicing fees								Administrative, distribution, and servicing fees
(in millions)	Investment advisory fees		Administrative fees		Distribution and servicing fees		Net revenues		Investment advisory fees		Administrative fees		Distribution and servicing fees		Net revenues
U.S. mutual funds	$	1,050.2	$	78.7	$	29.1	$	1,158.0	$	876.2	$	77.2	$	27.9	$	981.3
Subadvised funds, separate accounts, collective investment trusts, and other investment products	637.6		—		—		637.6		451.6		—		—		451.6
Other clients(1)	—		31.2		—		31.2		—		29.7		—		29.7
	$	1,687.8	$	109.9	$	29.1	$	1,826.8	$	1,327.8	$	106.9	$	27.9	$	1,462.6

(1) Other clients primarily include individuals, defined contribution plans, college savings plans, and institutions related to model delivery.    

Total net revenues earned from our related parties, specifically T. Rowe Price investment products, aggregate $1,482.3 million and $1,207.7 million for the three months ended March 31, 2021 and 2020, respectively. Accounts

Page 7

receivable from these products aggregate to $540.0 million at March 31, 2021, and $523.4 million at December 31, 2020.

In the second quarter of 2020, we changed our fee structure of the target date retirement funds such that our investment advisory fee revenue is now earned at the target date retirement fund level rather than at the underlying mutual fund level. As a result, we have modified our investment advisory fee and assets under management presentation below to separately breakout the fees earned and assets under management of our multi-asset portfolios. All prior periods have been recast to conform to this new presentation and to provide comparability.

The following table details the investment advisory fees earned from clients by their underlying asset class.

	Three months ended
(in millions)	3/31/2021		3/31/2020
U.S. mutual funds
Equity	$	729.8	$	568.4
Fixed income, including money market	59.0		71.7
Multi-asset	261.4		236.1
	1,050.2		876.2
Subadvised funds, separate accounts, collective investment trusts, and other investment products
Equity	429.8		279.5
Fixed income, including money market	31.7		38.0
Multi-asset	176.1		134.1
	637.6		451.6
Total	$	1,687.8	$	1,327.8

The following table summarizes the assets under management on which we earn investment advisory fees.

	Average during
	Three months ended				As of
(in billions)	3/31/2021		3/31/2020		3/31/2021		12/31/2020
U.S. mutual funds
Equity	$	509.6	$	388.3	$	511.7	$	498.6
Fixed income, including money market	82.3		75.7		82.6		79.4
Multi-asset	222.6		190.3		222.1		216.6
	814.5		654.3		816.4		794.6
Subadvised funds, separate accounts, collective investment trusts, and other investment products
Equity	418.9		277.5		405.5		397.2
Fixed income, including money market	80.2		81.3		90.2		89.3
Multi-asset	195.2		149.6		205.9		189.4
	694.3		508.4		701.6		675.9
Total	$	1,508.8	$	1,162.7	$	1,518.0	$	1,470.5

Investors that we serve are primarily domiciled in the U.S.; investment advisory clients outside the U.S. account for 8.8% and 9.3% of our assets under management at March 31, 2021, and December 31, 2020, respectively.

Page 8

NOTE 3 – INVESTMENTS.

The carrying values of our investments that are not part of the consolidated T. Rowe Price investment products are as follows:

(in millions)	3/31/2021		12/31/2020
Investments held at fair value
T. Rowe Price investment products
Discretionary investments	$	1,664.3	$	1,647.7
Seed capital	269.5		169.5
Supplemental savings plan liability economic hedges	766.9		768.1
Investment partnerships and other investments	100.6		95.1
Equity method investments
T. Rowe Price investment products
Discretionary investments	245.8		242.9
Seed capital	203.7		178.6
23% investment in UTI Asset Management Company Limited (India)	149.1		145.5
Investment partnerships and other investments	2.7		2.4
U.S. Treasury note	1.0		1.0
Total	$	3,403.6	$	3,250.8

The investment partnerships are carried at fair value using net asset value (“NAV”) per share as a practical expedient. Our interests in these partnerships are generally not redeemable and are subject to significant transferability restrictions. The underlying investments of these partnerships have contractual terms through 2029, though we may receive distributions of liquidating assets over a longer term. The investment strategies of these partnerships include growth equity, buyout, venture capital, and real estate.

During the three months ended March 31, 2021, net gains on investments included $38.8 million of net unrealized gains related to investments held at fair value that were still held at March 31, 2021. For the same period of 2020, net losses on investments included $103.6 million of net unrealized losses related to investments held at fair value that were still held at March 31, 2020.

During the three months ended March 31, 2021 and 2020, certain T. Rowe Price investment products in which we provided initial seed capital at the time of formation were deconsolidated, as we no longer had a controlling interest. Depending on our ownership interest, we are now reporting our residual interests in these T. Rowe Price investment products as either an equity method investment or an investment held at fair value. Additionally, during the three months ended March 31, 2020, certain T. Rowe Price investment products that were being accounted for as equity method investments were consolidated, as we regained a controlling interest. The net impact of these changes on our unaudited condensed consolidated balance sheets and statements of income as of the dates the portfolios were deconsolidated or reconsolidated is detailed below.

	Three months ended
(in millions)	3/31/2021		3/31/2020
Net decrease in assets of consolidated T. Rowe Price investment products	$	(928.1)	$	(46.2)
Net decrease in liabilities of consolidated T. Rowe Price investment products	$	(15.3)	$	(2.4)
Net decrease in redeemable non-controlling interests	$	(739.9)	$	(20.1)
Gains recognized upon deconsolidation	$	2.6	$	.1

The gains or losses recognized upon deconsolidation were the result of reclassifying currency translation adjustments accumulated on certain T. Rowe Price investment products with non-USD functional currencies from accumulated other comprehensive income to non-operating income.

Page 9

VARIABLE INTEREST ENTITIES.

Our investments at March 31, 2021 and December 31, 2020, include interests in variable interest entities that we do not consolidate as we are not deemed the primary beneficiary. Our maximum risk of loss related to our involvement with these entities is as follows:

(in millions)	3/31/2021		12/31/2020
Investment carrying values	$	289.6	$	144.7
Unfunded capital commitments	11.3		12.3
Accounts receivable	60.7		13.8
	$	361.6	$	170.8

The unfunded capital commitments totaling $11.3 million at March 31, 2021 and $12.3 million at December 31, 2020 relate primarily to the investment partnerships in which we have an existing investment. In addition to such amounts, a percentage of prior distributions may be called under certain circumstances.

NOTE 4 – FAIR VALUE MEASUREMENTS.

We determine the fair value of our cash equivalents and investments held at fair value using the following broad levels of inputs as defined by related accounting standards:

Level 1 – quoted prices in active markets for identical securities.

Level 2 – observable inputs other than Level 1 quoted prices including, but not limited to, quoted prices for similar

     securities, interest rates, prepayment speeds, and credit risk. These inputs are based on market data

     obtained from independent sources.

Level 3 – unobservable inputs reflecting our own assumptions based on the best information available. We do not

        value any investments using Level 3 inputs.

These levels are not necessarily an indication of the risk or liquidity associated with our investments. The following table summarizes our investments that are recognized in our unaudited condensed consolidated balance sheets using fair value measurements determined based on the differing levels of inputs. This table excludes investments held by the consolidated T. Rowe Price investment products which are presented separately on our unaudited condensed consolidated balance sheets and are detailed in Note 5.

	3/31/2021				12/31/2020
(in millions)	Level 1		Level 2		Level 1		Level 2
T. Rowe Price investment products
Cash equivalents held in money market funds	2,487.5		$	—	$	1,931.1	$	—
Discretionary investments	1,664.3		—		1,647.7		—
Seed capital	254.6		14.9		156.6		12.9
Supplemental savings plan liability economic hedges	766.9				768.1		—
Other investments	.2		.7		.5		.6
Total	$	5,173.5	$	15.6	$	4,504.0	$	13.5

The fair value hierarchy level table above does not include the investment partnerships and other investments for which fair value is estimated using their NAV per share as a practical expedient. The carrying value of these investments as disclosed in Note 3 were $99.7 million at March 31, 2021, and $94.0 million at December 31, 2020.

NOTE 5 – CONSOLIDATED T. ROWE PRICE INVESTMENT PRODUCTS.

The T. Rowe Price investment products that we consolidate in our unaudited condensed consolidated financial statements are generally those products we provided initial seed capital at the time of their formation and have a controlling interest. Our U.S. mutual funds are considered voting interest entities, while those regulated outside the U.S. are considered variable interest entities.

Page 10

The following table details the net assets of the consolidated T. Rowe Price investment products:

	3/31/2021						12/31/2020
(in millions)	Voting interest entities		Variable interest entities		Total		Voting interest entities		Variable interest entities		Total
Cash and cash equivalents(1)	$	3.0	$	80.7	$	83.7	$	7.1	$	97.7	$	104.8
Investments(2)	157.5		1,664.5		1,822.0		188.2		2,372.7		2,560.9
Other assets	3.4		37.7		41.1		2.8		27.0		29.8
Total assets	163.9		1,782.9		1,946.8		198.1		2,497.4		2,695.5
Liabilities	4.7		49.0		53.7		10.0		47.7		57.7
Net assets	$	159.2	$	1,733.9	$	1,893.1	$	188.1	$	2,449.7	$	2,637.8
Attributable to T. Rowe Price Group	$	96.4	$	783.8	$	880.2	$	130.7	$	945.4	$	1,076.1
Attributable to redeemable non-controlling interests	62.8		950.1		1,012.9		57.4		1,504.3		1,561.7
	$	159.2	$	1,733.9	$	1,893.1	$	188.1	$	2,449.7	$	2,637.8

(1) Cash and cash equivalents includes $2.8 million at March 31, 2021, and $7.0 million at December 31, 2020, of T. Rowe Price money market mutual funds.

(2) Investments include $24.4 million at March 31, 2021, and $26.9 million at December 31, 2020 of other T. Rowe Price investment products.

Although we can redeem our net interest in these consolidated T. Rowe Price investment products at any time, we cannot directly access or sell the assets held by these products to obtain cash for general operations. Additionally, the assets of these investment products are not available to our general creditors.

Since third party investors in these investment products have no recourse to our credit, our overall risk related to the net assets of consolidated T. Rowe Price investment products is limited to valuation changes associated with our net interest. We, however, are required to recognize the valuation changes associated with all underlying investments held by these products in our unaudited condensed consolidated statements of income and disclose the portion attributable to third party investors as net income attributable to redeemable non-controlling interests.

The operating results of the consolidated T. Rowe Price investment products for the three months ended March 31, 2021 and 2020, are reflected in our unaudited condensed consolidated statements of income as follows:

	Three months ended
	3/31/2021						3/31/2020
(in millions)	Voting interest entities		Variable interest entities		Total		Voting interest entities		Variable interest entities		Total
Operating expenses reflected in net operating income	$	(.2)	$	(3.3)	$	(3.5)	$	(.2)	$	(3.5)	$	(3.7)
Net investment income (loss) reflected in non-operating income (loss)	6.1		31.1		37.2		(35.2)		(295.1)		(330.3)
Impact on income before taxes	$	5.9	$	27.8	$	33.7	$	(35.4)	$	(298.6)	$	(334.0)
Net income (loss) attributable to T. Rowe Price Group	$	4.0	$	14.3	$	18.3	$	(22.6)	$	(134.9)	$	(157.5)
Net income (loss) attributable to redeemable non-controlling interests	1.9		13.5		15.4		(12.8)		(163.7)		(176.5)
	$	5.9	$	27.8	$	33.7	$	(35.4)	$	(298.6)	$	(334.0)

The operating expenses of the consolidated investment products are reflected in other operating expenses. In preparing our unaudited condensed consolidated financial statements, we eliminated operating expenses of $1.3 million and $2.5 million for the three months ended March 31, 2021 and 2020, respectively, against the investment advisory and administrative fees earned from these products. The net investment income (loss) reflected in non-

Page 11

operating income (loss) includes dividend and interest income and realized and unrealized gains and losses on the underlying securities held by the consolidated T. Rowe Price investment products.

The table below details the impact of these consolidated investment products on the individual lines of our unaudited condensed consolidated statements of cash flows for the three months ended March 31, 2021 and 2020.

	Three months ended
	3/31/2021						3/31/2020
(in millions)	Voting interest entities		Variable interest entities		Total		Voting interest entities		Variable interest entities		Total
Net cash provided by (used in) operating activities	$	(31.7)	$	(112.0)	$	(143.7)	$	11.3	$	(87.0)	$	(75.7)
Net cash used in investing activities	(9.1)		(18.2)		(27.3)		(.8)		—		(.8)
Net cash provided by financing activities	36.7		112.3		149.0		2.7		116.2		118.9
Effect of exchange rate changes on cash and cash equivalents of consolidated T. Rowe Price investment products	—		.9		.9		—		(1.2)		(1.2)
Net change in cash and cash equivalents during period	(4.1)		(17.0)		(21.1)		13.2		28.0		41.2
Cash and cash equivalents at beginning of year	7.1		97.7		104.8		9.9		66.6		76.5
Cash and cash equivalents at end of period	$	3.0	$	80.7	$	83.7	$	23.1	$	94.6	$	117.7

The net cash provided by financing activities during the three months ended March 31, 2021 and 2020 includes $34.1 million and $42.8 million, respectively, of net subscriptions we made into the consolidated T. Rowe Price investment products, net of dividends received. These cash flows were eliminated in consolidation.

FAIR VALUE MEASUREMENTS.

We determine the fair value of investments held by consolidated T. Rowe Price investment products using the following broad levels of inputs as defined by related accounting standards:

Level 1 – quoted prices in active markets for identical securities.

Level 2 – observable inputs other than Level 1 quoted prices including, but not limited to, quoted prices for similar securities, interest rates, prepayment speeds, and credit risk. These inputs are based on market data obtained from independent sources.

Level 3 – unobservable inputs reflecting our own assumptions based on the best information available. The value of investments using Level 3 inputs is insignificant.

These levels are not necessarily an indication of the risk or liquidity associated with these investment holdings. The following table summarizes the investment holdings held by our consolidated T. Rowe Price investment products using fair value measurements determined based on the differing levels of inputs.

	3/31/2021				12/31/2020
(in millions)	Level 1		Level 2		Level 1		Level 2
Assets
Cash equivalents	$	2.8	$	—	$	7.0	$	—
Equity securities	225.7		449.9		308.0		708.0
Fixed income securities	—		1,107.2		—		1,411.3
Other investments	4.0		35.2		2.6		131.0
	$	232.5	$	1,592.3	$	317.6	$	2,250.3
Liabilities	$	(.4)	$	(9.9)	$	(.4)	$	(18.8)

Page 12

NOTE 6 – STOCKHOLDERS’ EQUITY.

Accounts payable and accrued expenses includes liabilities of $10.9 million at March 31, 2021, and $2.5 million at December 31, 2020, for common stock repurchases that settled during the first week of April 2021 and January 2021, respectively.

NOTE 7 – STOCK-BASED COMPENSATION.

STOCK OPTIONS.

The following table summarizes the status of, and changes in, our stock options during the three months ended March 31, 2021.

	Options	Weighted- average exercise price
Outstanding at December 31, 2020	4,329,056	$	72.52
Exercised	(748,203)	$	72.28
Outstanding at March 31, 2021	3,580,853	$	72.57
Exercisable at March 31, 2021	3,580,853	$	72.57

RESTRICTED SHARES AND STOCK UNITS.

The following table summarizes the status of, and changes in, our nonvested restricted shares and restricted stock units during the three months ended March 31, 2021.

	Restricted shares	Restricted stock units	Weighted-average fair value
Nonvested at December 31, 2020	7,412	6,367,059	$	116.51
Time-based grants	—	3,397	$	154.03
Dividend equivalents granted to non-employee directors	—	550	$	172.22
Vested	—	(64,942)	$	97.37
Forfeited	—	(19,489)	$	114.66
Nonvested at March 31, 2021	7,412	6,286,575	$	116.73

Nonvested at March 31, 2021, includes performance-based restricted stock units of 361,609. These nonvested performance-based restricted stock units include 198,205 units for which the performance period has lapsed, and the performance threshold has been met.

FUTURE STOCK-BASED COMPENSATION EXPENSE.

The following table presents the compensation expense to be recognized over the remaining vesting periods of the stock-based awards outstanding at March 31, 2021. Estimated future compensation expense will change to reflect future grants of restricted stock awards and units, future option grants, changes in the probability of performance thresholds being met, and adjustments for actual forfeitures.

(in millions)
Second quarter 2021	$	56.9
Third quarter 2021	56.7
Fourth quarter 2021	50.2
2022	117.4
2023 through 2026	97.2
Total	$	378.4

Page 13

NOTE 8 – EARNINGS PER SHARE CALCULATIONS.

The following table presents the reconciliation of net income attributable to T. Rowe Price Group to net income allocated to our common stockholders and the weighted-average shares that are used in calculating the basic and diluted earnings per share on our common stock. Weighted-average common shares outstanding assuming dilution reflects the potential dilution, determined using the treasury stock method, that could occur if outstanding stock options were exercised and non-participating stock awards vested. No outstanding stock options had an anti-dilutive impact on the diluted earnings per common share calculation in the periods presented.

	Three months ended
(in millions)	3/31/2021		3/31/2020
Net income attributable to T. Rowe Price Group	749.4		$	343.1
Less: net income allocated to outstanding restricted stock and stock unit holders	19.9		9.4
Net income allocated to common stockholders	$	729.5	$	333.7
Weighted-average common shares
Outstanding	227.7		234.1
Outstanding assuming dilution	230.0		236.8

NOTE 9 – OTHER COMPREHENSIVE INCOME AND ACCUMULATED OTHER COMPREHENSIVE LOSS.

The changes in each component of accumulated other comprehensive loss, including reclassification adjustments for the three months ended March 31, 2021 and 2020 are presented in the table below.

	Three months ended 3/31/2021						Three months ended 3/31/2020
(in millions)	Equity method investments		Consolidated T. Rowe Price investment products - variable interest entities		Total currency translation adjustments		Equity method investments		Consolidated T. Rowe Price investment products - variable interest entities		Total currency translation adjustments
Balances at beginning of period	$	(43.6)	$	20.6	$	(23.0)	$	(46.9)	$	3.9	$	(43.0)
Other comprehensive income (loss) before reclassifications and income taxes	(.8)		(7.1)		(7.9)		(.1)		(7.9)		(8.0)
Reclassification adjustments recognized in non-operating income	—		(2.6)		(2.6)		—		(.1)		(.1)
	(.8)		(9.7)		(10.5)		(.1)		(8.0)		(8.1)
Net deferred tax benefits (income taxes)	.5		2.5		3.0		—		2.0		2.0
Other comprehensive income (loss)	(.3)		(7.2)		(7.5)		(.1)		(6.0)		(6.1)
Balances at end of period	$	(43.9)	$	13.4	$	(30.5)	$	(47.0)	$	(2.1)	$	(49.1)

The other comprehensive income (loss) in the table above excludes $11.8 million and $17.2 million of other comprehensive loss related to redeemable non-controlling interests held in our consolidated products for the three months ended March 31, 2021 and 2020, respectively.

Page 14

NOTE 10 – COMMITMENTS AND CONTINGENCIES.

On February 14, 2017, T. Rowe Price Group, Inc., T. Rowe Price Associates, Inc., T. Rowe Price Trust Company, current and former members of the management committee, and trustees of the T. Rowe Price U.S. Retirement Program were named as defendants in a lawsuit filed in the United States District Court for the District of Maryland. The lawsuit alleges breaches of ERISA’s fiduciary duty and prohibited transaction provisions on behalf of a class of all participants and beneficiaries of the T. Rowe Price 401(k) Plan from February 14, 2011, to the time of judgment. The matter has been certified as a class action. T. Rowe Price believes the claims are without merit and is vigorously defending the action. The parties each filed motions for summary judgment and, with the exception of one claim, the court has denied the parties’ cross motions for summary judgment. A trial has been scheduled to begin in September 2021. We cannot predict the eventual outcome, or whether it will have a material negative impact on our financial results, or estimate the possible loss or range of loss that may arise from any negative outcome.

In addition to the matter discussed above, various claims against us arise in the ordinary course of business, including employment-related claims. In the opinion of management, after consultation with counsel, the likelihood of an adverse determination in one or more of these pending ordinary course of business claims that would have a material adverse effect on our financial position or results of operations is remote.

Page 15

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Stockholders and Board of Directors

T. Rowe Price Group, Inc.:

Results of Review of Interim Financial Information

We have reviewed the condensed consolidated balance sheet of T. Rowe Price Group, Inc. and subsidiaries (the “Company") as of March 31, 2021, the related condensed consolidated statements of income and comprehensive income, stockholders’ equity, and cash flows for the three-month periods ended March 31, 2021 and 2020, and the related notes (collectively, the consolidated interim financial information). Based on our reviews, we are not aware of any material modifications that should be made to the consolidated interim financial information for it to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheet of the Company as of December 31, 2020, and the related consolidated statements of income, comprehensive income, stockholders’ equity, and cash flows for the year then ended (not presented herein); and in our report dated February 11, 2021, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2020, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

Basis for Review Results

This consolidated interim financial information is the responsibility of the Company’s management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our reviews in accordance with the standards of the PCAOB. A review of consolidated interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

/s/ KPMG LLP

Baltimore, Maryland

April 29, 2021

Page 16

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations.

OVERVIEW.

Our revenues and net income are derived primarily from investment advisory services provided to individual and institutional investors in U.S. mutual funds, subadvised funds, separately managed accounts, collective investment trusts, and other T. Rowe Price products. The other T. Rowe Price products include open-ended investment products offered to investors outside the U.S., and products offered through variable annuity life insurance plans in the U.S. We also provide certain investment advisory clients with related administrative services, including distribution, mutual fund transfer agent, accounting, and shareholder services; participant recordkeeping and transfer agent services for defined contribution retirement plans; brokerage; trust services; and non-discretionary advisory services through model delivery.

We manage a broad range of U.S., international and global stock, bond, and money market mutual funds and collective investment trusts and other investment products, which meet the varied needs and objectives of individual and institutional investors. Investment advisory revenues depend largely on the total value and composition of assets under our management. Accordingly, fluctuations in financial markets and in the composition of assets under management affect our revenues and results of operations. Additionally, approximately 30% of our operating expenses are impacted by fluctuations in our assets under management.

We incur significant expenditures to develop new products and services and improve and expand our capabilities and distribution channels in order to attract new investment advisory clients and additional investments from our existing clients. These efforts often involve costs that precede any future revenues that we may recognize from an increase to our assets under management.

The general trend to passive investing has been persistent and accelerated in recent years, which has negatively impacted our new client inflows. However, over the long term we expect well-executed active management to play an important role for investors. In this regard, we remain debt-free with ample liquidity and resources that allow us to take advantage of attractive growth opportunities. We are investing in key capabilities, including investment professionals, distribution professionals, technologies, and new product offerings in order to provide our clients with strong investment management expertise and service.

MARKET TRENDS.

U.S. equities generated strong returns in the first quarter of 2021, a continuation of a remarkably robust stock market given the pandemic and related economic dislocations. Most major U.S. equity indexes hit all-time highs during the quarter, although the market was led by shares of smaller companies as well as value stocks and cyclical businesses that are closely tied to the health of the economy. Technology and other growth stocks trailed.

In general, equities were lifted by the accelerating rollout of coronavirus vaccines, favorable economic data and corporate earnings reports, and expectations for new federal fiscal stimulus measures. Although Congress passed a $1.9 trillion coronavirus relief bill in March and the Biden administration prepared to pursue a significant increase in infrastructure spending, some investors were concerned about a sharp increase in longer-term U.S. Treasury yields during the quarter and possibly higher inflation later in 2021.

Stocks in developed non-U.S. equity markets advanced but underperformed U.S. equities; a stronger U.S. dollar versus several key currencies weighed on local returns in U.S. dollar terms. European stock markets were mostly positive despite the reinstatement of lockdown measures in some countries. Most developed Asian and Far East markets posted gains; Japanese shares rose less than 2%.

Emerging markets stocks also advanced but underperformed developed markets, hurt in part by rising U.S. Treasury yields and a stronger U.S. dollar against many currencies. Latin American markets were mostly negative in dollar terms. Asian market returns varied widely. In emerging Europe, Turkish shares and the lira tumbled as the Turkish president unexpectedly replaced the head of the central bank shortly after an interest rate increase in March.

Page 17

Returns of several major equity market indexes were as follows:

	Three months ended
Index	3/31/2021
S&P 500 Index	6.2%
NASDAQ Composite Index(1)	2.8%
Russell 2000 Index	12.7%
MSCI EAFE (Europe, Australasia, and Far East) Index	3.6%
MSCI Emerging Markets Index	2.3%

 (1) Returns exclude dividends

Global bond returns were mostly negative in U.S. dollar terms. In the U.S., high yield securities benefited from favorable corporate earnings and expectations of a stronger economy to post gains. Higher-quality securities with greater interest rate sensitivity were hurt by a sharp increase in intermediate- and long-term U.S. Treasury yields. The Federal Reserve kept short-term interest rates near 0%, but the 10-year U.S. Treasury note yield increased from 0.93% to 1.74%. Longer-term corporate and U.S. Treasury bonds were among the worst performers. Mortgage- and asset-backed securities fell to a lesser extent. Tax-free municipal bonds held up relatively well, helped by the prospect of more federal aid to shore up state and local finances.

Bonds in developed non-U.S. markets declined in U.S. dollar terms, hurt by rising longer-term interest rates in local markets and weaker currencies versus the U.S. dollar. The British pound, however, appreciated about 1% versus the dollar.

Emerging markets bonds also produced negative returns as longer-term interest rates generally increased and a few countries also raised short-term rates. Local currency issues underperformed bonds denominated in dollars as many currencies, especially the Turkish lira and the Brazilian real, weakened versus the dollar.

Returns for several major bond market indexes were as follows:

	Three months ended
Index	3/31/2021
Bloomberg Barclays U.S. Aggregate Bond Index	(3.4)%
JPMorgan Global High Yield Index	1.2%
Bloomberg Barclays Municipal Bond Index	(.4)%
Bloomberg Barclays Global Aggregate Ex-U.S. Dollar Bond Index	(5.3)%
JPMorgan Emerging Markets Bond Index Plus	(7.2)%

Page 18

ASSETS UNDER MANAGEMENT.

Assets under management ended the first quarter of 2021 at $1,518.0 billion, an increase of $47.5 billion from December 31, 2020. This increase was driven by market appreciation, net of distributions not reinvested, of $46.3 billion and net cash inflows of $1.2 billion. Clients transferred $5.6 billion in net assets from the U.S. mutual funds to collective investment trusts and other investment products, of which $4.9 billion transferred into the retirement date trusts.

The following tables detail changes in our assets under management, by vehicle and asset class, during the first quarter of 2021:

	Three months ended 3/31/2021
(in billions)	U.S. mutual funds		Subadvised funds and separate accounts		Collective investment trusts and other investment products		Total
Assets under management at beginning of period	$	794.6	$	400.1	$	275.8	$	1,470.5
Net cash flows before client transfers	2.0		(8.2)		7.4		1.2
Client transfers	(5.6)		—		5.6		—
Net cash flows after client transfers	(3.6)		(8.2)		13.0		1.2
Net market appreciation and gains	25.5		11.9		9.0		46.4
Net distributions not reinvested	(.1)		—		—		(.1)
Change during the period	21.8		3.7		22.0		47.5
Assets under management at March 31, 2021	$	816.4	$	403.8	$	297.8	$	1,518.0

	Three months ended 3/31/2021
(in billions)	Equity		Fixed income, including money market		Multi-asset(1)		Total
Assets under management at beginning of period	$	895.8	$	168.7	$	406.0	$	1,470.5
Net cash flows	(8.9)		5.4		4.7		1.2
Net market appreciation and gains(2)	30.3		(1.3)		17.3		46.3
Change during the period	21.4		4.1		22.0		47.5
Assets under management at March 31, 2021	$	917.2	$	172.8	$	428.0	$	1,518.0

(1) The underlying assets under management of the multi-asset portfolios have been aggregated and presented in this category and not reported in the equity and fixed income columns.

(2) Includes distributions reinvested and not reinvested.

Investment advisory clients outside the United States account for about 8.8% of our assets under management at March 31, 2021 and 9.3% at December 31, 2020.

Our target date retirement products, which are included in the multi-asset totals shown above, continue to be a significant part of our assets under management. Assets under management in these portfolios, as well as net cash inflows (outflows), by vehicle, were as follows:

	Assets under management				Net cash inflows (outflows) for three months ended
(in billions)	3/31/2021		12/31/2020		3/31/2021		3/31/2020
U.S. mutual funds	$	179.9	$	176.1	$	(3.8)	$	(5.0)
Collective investment trusts	160.3		145.4		8.1		5.6
Separately managed accounts	11.4		10.7		.2		.1
	$	351.6	$	332.2	$	4.5	$	.7

We provide participant accounting and plan administration for defined contribution retirement plans that invest in the firm's U.S. mutual funds, collective investment trusts and funds outside of the firm's complex. As of March 31, 2021, our assets under administration were $248 billion, of which nearly $153 billion are assets we manage. In recent years, we began offering non-discretionary advisory services through model delivery, which are managed accounts where portfolio holdings and trades in the portfolio are provided to sponsor platforms to implement for their clients.

Page 19

We record the revenue earned on these services in administrative fees. The assets under advisement in these portfolios, predominantly in the United States, is $3 billion at March 31, 2021.

INVESTMENT PERFORMANCE.

Strong investment performance and brand awareness is a key driver to attracting and retaining assets—and to our long-term success. Our performance disclosures include specific asset classes, assets under management weighted performance, mutual fund performance against passive peers and composite performance against benchmarks. The following table presents investment performance for the one-, three-, five-, and 10-years ended March 31, 2021. Past performance is no guarantee of future results.

% of U.S. mutual funds that outperformed Morningstar median(1),(2)
	1 year	3 years	5 years	10 years
Equity	65%	68%	67%	87%
Fixed Income	71%	60%	55%	57%
Multi-Asset	94%	94%	91%	90%
All Funds	75%	73%	70%	78%
% of U.S. mutual funds that outperformed passive peer median(1),(3)
	1 year	3 years	5 years	10 years
Equity	57%	58%	62%	72%
Fixed Income	91%	59%	57%	60%
Multi-Asset	94%	91%	87%	86%
All Funds	78%	68%	68%	72%
% of composites that outperformed benchmarks(4)
	1 year	3 years	5 years	10 years
Equity	55%	60%	73%	78%
Fixed Income	87%	69%	80%	72%
All Composites	68%	63%	76%	76%

AUM Weighted Performance
% of U.S. mutual funds AUM that outperformed Morningstar median(1),(2)
	1 year	3 years	5 years	10 years
Equity	63%	65%	83%	94%
Fixed Income	79%	58%	59%	60%
Multi-Asset	100%	96%	96%	96%
All Funds	73%	72%	84%	92%
% of U.S. mutual funds AUM that outperformed passive peer median(1),(3)
	1 year	3 years	5 years	10 years
Equity	51%	53%	81%	81%
Fixed Income	97%	52%	56%	64%
Multi-Asset	98%	96%	96%	96%
All Funds	66%	63%	83%	84%
% of composites AUM that outperformed benchmarks(4)
	1 year	3 years	5 years	10 years
Equity	51%	65%	72%	79%
Fixed Income	88%	54%	73%	72%
All Composites	57%	64%	73%	79%

Page 20

As of March 31, 2021, 80 of 123 (65.0%) of the firm's rated U.S. mutual funds (across primary share classes) received an overall rating of 4 or 5 stars. By comparison, 32.5% of Morningstar's fund population is given a rate of 4 or 5 stars(5). In addition, 88%(5) of AUM in the firm's rated U.S. mutual funds (across primary share classes) ended March 31, 2021 with an overall rating of 4 or 5 stars.

(1) Source: © 2021 Morningstar, Inc. All rights reserved. The information contained herein: 1) is proprietary to Morningstar and/or its content providers; 2) may not be copied or distributed; and 3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

(2) Source: Morningstar. Primary share class only. Excludes money market mutual funds, funds with an operating history of less than one year, T. Rowe Price passive funds, and T. Rowe Price funds that are clones of other funds. The top chart reflects the percentage of T. Rowe Price funds with 1 year, 3 year, 5 year, and 10 year track record that are outperforming the Morningstar category median. The bottom chart reflects the percentage of T. Rowe Price funds AUM that has outperformed for the time periods indicated. Total AUM included for this analysis includes $503B for 1 year, $503B for 3 years, $503B for 5 years, and $493B for 10 years.

(3) Passive Peer Median was created by T. Rowe Price using data from Morningstar. Primary share class only. Excludes money market mutual funds, funds with an operating history of less than one year, funds with fewer than three peers, T. Rowe Price passive funds, and T. Rowe Price funds that are clones of other funds. This analysis compares T. Rowe Price active funds to the applicable universe of passive/index open-end funds and ETFs of peer firms. The top chart reflects the percentage of T. Rowe Price funds with 1 year, 3 year, 5 year, and 10 year track record that are outperforming the passive peer universe. The bottom chart reflects the percentage of T. Rowe Price funds AUM that has outperformed for the time periods indicated. Total AUM included for this analysis includes $491B for 1 year, $482B for 3 years, $439B for 5 years, and $416B for 10 years.

(4)Composite net returns are calculated using the highest applicable separate account fee schedule. Excludes money market composites. All composites compared to official GIPS composite primary benchmark. The top chart reflects the percentage of T. Rowe Price composites with 1 year, 3 year, 5 year, and 10 year track record that are outperforming their benchmarks. The bottom chart reflects the percentage of T. Rowe Price composite AUM that has outperformed for the time periods indicated. Total AUM included for this analysis includes $1,392B for 1 year, $1,388B for 3 years, $1,364B for 5 years, and $1,316B for 10 years.

(5) The Morningstar Rating™ for funds is calculated for funds with at least a three-year history. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. Morningstar gives its best ratings of 5 or 4 stars to the top 32.5% of all funds (of the 32.5%,10% get 5 stars and 22.5% get 4 stars). The Overall Morningstar Rating™ is derived from a weighted average of the performance figures associated with a fund’s 3, 5, and 10 year (if applicable) Morningstar Rating™ metrics.

RESULTS OF OPERATIONS.

The following table and discussion sets forth information regarding our consolidated financial results for the three months ended March 31, 2021 and 2020 on a U.S. GAAP basis as well as a non-GAAP basis. The non-GAAP basis adjusts for the impact of our consolidated T. Rowe Price investment products, the impact of market movements on the supplemental savings plan liability and related economic hedges, investment income related to certain other investments, and certain nonrecurring charges and gains, if any.

	Three months ended				Q1 2021 vs. Q1 2020
(in millions, except per-share data)	3/31/2021		3/31/2020		$ change		% change
U.S. GAAP basis
Investment advisory fees	$	1,687.8	$	1,327.8	$	360.0	27.1	%
Net revenues	$	1,826.8	$	1,462.6	$	364.2	24.9	%
Operating expenses	$	933.6	$	755.4	$	178.2	23.6	%
Net operating income	$	893.2	$	707.2	$	186.0	26.3	%
Non-operating income (loss)(1)	$	102.1	$	(500.3)	$	602.4	n/m
Net income attributable to T. Rowe Price Group	$	749.4	$	343.1	$	406.3	118.4	%
Diluted earnings per common share	$	3.17	$	1.41	$	1.76	124.8	%
Weighted average common shares outstanding assuming dilution	230.0		236.8		(6.8)		(2.9)	%
Adjusted non-GAAP basis(2)
Operating expenses	$	909.2	$	817.9	$	91.3	11.2	%
Net operating income	$	918.9	$	647.2	$	271.7	42.0	%
Non-operating income (loss)(1)	$	13.7	$	(61.2)	$	74.9	n/m
Net income attributable to T. Rowe Price Group	$	712.0	$	454.3	$	257.7	56.7	%
Diluted earnings per common share	$	3.01	$	1.87	$	1.14	61.0	%
Assets under management (in billions)
Average assets under management	$	1,508.8	$	1,162.7	$	346.1	29.8	%
Ending assets under management	$	1,518.0	$	1,008.8	$	509.2	50.5	%

(1) The percentage change in non-operating income (loss) is not meaningful (n/m).

(2) See the reconciliation to the comparable U.S. GAAP measures at the end of the Results of Operations section of this Management’s Discussion and Analysis.

Results Overview - Quarter ended March 31, 2021

Investment advisory revenues. Investment advisory fees are earned based on the value and composition of our assets under management, which change based on fluctuations in financial markets and net cash flows. As our average assets under management increase or decrease in a given period, the level of our investment advisory fee

Page 21

revenue for that same period generally fluctuates in a similar manner. Our annualized effective fee rates can be impacted by market or cash flow related shifts among asset and share classes, price changes in existing products, and asset level changes in products with tiered-fee structures.

Investment advisory revenues earned in the first quarter of 2021 increased over the comparable 2020 quarter as average assets under our management increased $346.1 billion, or 29.8%, to $1,508.8 billion. In the first quarter of 2021, we voluntarily waived $15.0 million, or less than 1%, of our investment advisory fees in order to continue to maintain a positive yield for investors. At March 31, 2021, combined net assets of the investment portfolios in which we waived fees in the first quarter of 2021 were $29.5 billion. We expect to continue to waive fees for all of 2021 and anticipate that the waivers in each of the next three quarters of 2021 will be at similar levels.

The average annualized effective fee rate earned during the first quarter of 2021 was 45.4 basis points, compared with 45.9 basis points earned during the first quarter of 2020 and 45.7 basis points during the fourth quarter of 2020. In comparison to the first quarter of 2020, our annualized effective fee rate declined primarily due to client transfers within the complex to lower fee vehicles or share classes over the last twelve months and the money market fee waivers. In comparison to the fourth quarter of 2020, our average annualized effective fee rate declined primarily due to lower performance fees earned in 2021.

Operating expenses. Operating expenses were $933.6 million in the first quarter of 2021 compared with $755.4 million in the first quarter of 2020. Nearly half of the increase in operating expenses for the first quarter of 2021 compared to the first quarter of 2020 was due to an $85.9 million increase in expense related to the supplemental savings plan from higher market returns. The remaining increase was due primarily to higher compensation expenses as well as distribution and servicing costs. For the first quarter of 2021, the higher expense related to the supplemental savings plan was almost entirely offset by the non-operating gains earned on the investments used to economically hedge the related liability.

On a non-GAAP basis, our operating expenses in the first quarter of 2021 increased 11.2% to $909.2 million compared to the first quarter of 2020. Our non-GAAP operating expenses do not include the impact of our supplemental savings plan and consolidated sponsored investment products. See our non-GAAP reconciliations later in this Management’s Discussion and Analysis section.

In 2021 and beyond, we expect to advance our strategic priorities to maintain our position as a global and diversified asset manager, a global partner for retirement investors and a provider of integrated investment solutions; to embed environmental, social and governance principles across the firm; to maintain effective processes and controls while becoming a more adaptive and agile firm; and to become a destination of choice for top talent with a diverse workforce and inclusive culture. We updated our 2021 non-GAAP operating expense growth guidance from a range of 8% - 12% to a range of 10% - 14% to reflect an increase in our expectations for AUM-related expenses. We can elect to adjust our expense growth in the future should unforeseen circumstances arise, including significant market movements.

Operating margin. Our operating margin in the first quarter of 2021 was 48.9%, compared to 48.4% earned in the 2020 quarter. The increase in our operating margin for the first quarter of 2021 compared to the 2020 period was primarily driven by higher investment advisory fee revenue, partially offset by the higher expense related to our supplemental savings plan, as market returns in the first quarter of 2021 outperformed the same period in 2020.

Diluted earnings per share. Diluted earnings per share was $3.17 for the first quarter of 2021 as compared to $1.41 for the first quarter of 2020. The 124.8% increase was primarily driven by the net investment gains recognized in the first quarter of 2021 as compared to significant investment losses recognized in the first quarter of 2020 following sharp market declines at the end of March 2020.

On a non-GAAP basis, diluted earnings per share was $3.01 for the first quarter of 2021 as compared to $1.87 for the first quarter of 2020. The increase in diluted earnings per share was primarily due to higher operating income as well as net gains earned on our cash and discretionary investments in the 2021 quarter compared with investment losses in the 2020 period.

Page 22

Net revenues

	Three months ended				Q1 2021 vs. Q1 2020
(in millions)	3/31/2021		3/31/2020		$ change		% change
Investment advisory fees
U.S. mutual funds	$	1,050.2	$	876.2	$	174.0	19.9	%
Subadvised funds, separate accounts, collective investment trusts, and other investment products	637.6		451.6		186.0		41.2	%
	1,687.8		1,327.8		360.0		27.1	%
Administrative, distribution, and servicing fees
Administrative fees	109.9		106.9		3.0		2.8	%
Distribution and servicing fees	29.1		27.9		1.2		4.3	%
	139.0		134.8		4.2		3.1	%
Net revenues	$	1,826.8	$	1,462.6	$	364.2	24.9	%

Investment advisory fees.

U.S. mutual funds

Investment advisory revenues earned in the first quarter of 2021 from our U.S. mutual funds were $1,050.2 million, an increase of 19.9% from the comparable 2020 quarter. Average assets under management in these funds for the first quarter of 2021 increased 24.5% from the 2020 quarter to $814.5 billion.

For the first quarter of 2021, the relationship between U.S. mutual funds’ average assets under management and investment advisory fee growth was impacted primarily by the money market fee waivers. In addition, strong market returns led to a decrease in the fee earned as the asset levels of certain tiered-fee funds crossed a new tier.

Subadvised funds, separate accounts, collective investment trusts and other investment products (other portfolios)

Investment advisory revenues earned in the first quarter of 2021 from these other portfolios were $637.6 million, an increase of 41.2% from the comparable 2020 quarter. Average assets under management for these products increased 36.6% from the 2020 quarter to $694.3 billion.

For the other portfolios, inflows into our international products, which have a higher fee rate relative to other products, and performance-based fees earned on certain separate accounts drove investment advisory revenues to outpace the increase in average assets under management.

These investment advisory revenues include distribution-related services we provide to the international products and then contract with third-party intermediaries to distribute these products. The costs we incur to pay the third-party intermediaries are recorded as part of distribution and servicing expenses.

Administrative, distribution, and servicing fees. Administrative, distribution, and servicing fees in the first quarter of 2021 were $139.0 million, an increase of $4.2 million, or 3.1%, from the comparable 2020 quarter. The increase was primarily due to higher transfer agent servicing activities provided to the U.S. mutual funds, higher model delivery revenue, as well as higher 12b-1 revenue earned on the R share class of the U.S. mutual funds as a result of increased assets under management in this share class. The increase in 12b-1 revenue is offset entirely by an increase in the costs paid to third-party intermediaries that source these assets and reported in distribution and servicing expense.

Our net revenues reflect the elimination of advisory and administrative fee revenue earned from our consolidated

T. Rowe Price investment products. The corresponding expenses recognized by these products, and consolidated in our financial statements, were also eliminated from operating expenses. For the first quarter, we eliminated net revenue of $1.3 million in 2021 and $2.5 million in 2020.

Page 23

Operating expenses

	Three months ended				Q1 2021 vs. Q1 2020
(in millions)	3/31/2021		3/31/2020		$ change		% change
Compensation and related costs, excluding supplemental savings plan	$	561.3	$	504.4	$	56.9	11.3	%
Supplemental savings plan(1)	22.2		(63.7)		85.9		n/m
Total compensation and related costs	583.5		440.7		142.8		32.4	%
Distribution and servicing	85.6		65.7		19.9		30.3	%
Advertising and promotion	18.9		24.9		(6.0)		(24.1)	%
Product-related costs	41.0		41.6		(.6)		(1.4)	%
Technology, occupancy, and facility costs	117.3		105.4		11.9		11.3	%
General, administrative, and other	87.3		77.1		10.2		13.2	%
Total operating expenses	$	933.6	$	755.4	$	178.2	23.6	%

(1) The impact of the market on the supplemental savings plan liability drives the expense recognized each period.

Compensation and related costs, excluding supplemental savings plan. Compensation and related costs, excluding supplemental savings plan, were $561.3 million in the first quarter of 2021, an increase of $56.9 million, or 11.3%, compared to the 2020 quarter. The increase from the 2020 quarter was primarily due to strong operating results in the first quarter of 2021 that led to a $36.3 million increase in our interim accrual for annual variable compensation, primarily bonus compensation. Also contributing to the increase in 2021 costs compared to the first quarter of 2020 was a $22.6 million increase in salaries and benefits due to a 3.4% increase in our average staff size and modest increases in base salaries at the beginning of the year. These increases in compensation and related costs were offset in part by higher labor capitalization related to internally developed software.

Distribution and servicing. Distribution and servicing costs were $85.6 million for the first quarter of 2021, an increase of 30.3% from the $65.7 million recognized in the 2020 quarter. The increase is primarily driven by higher distribution costs as a result of continued inflows and market appreciation in our international products, including our Japanese Investment Trusts (ITMs) and SICAVs.

Distribution and servicing costs paid to third-party intermediaries that source the assets of certain share classes of our U.S. mutual funds and our international products, such as our Japanese ITMs and SICAVs, are recognized in this expense. Both of these costs are offset entirely by the revenue we earn and report in net revenues: 12b-1 revenue recognized in administrative, distribution, and servicing fees for the U.S. mutual funds and investment advisory fee revenue for our international products.

Advertising and promotion. Advertising and promotion costs were $18.9 million in the first quarter of 2021, a decrease of $6.0 million, or 24.1%, compared to the $24.9 million recognized in the 2020 quarter. The decrease is driven primarily by the timing of media-related spend as well as fewer conference and promotional events since the later part of the first quarter of 2020 due to the coronavirus pandemic.

Technology, occupancy, and facility costs. Technology, occupancy, and facility costs were $117.3 million in the first quarter of 2021, an increase of $11.9 million, or 11.3%, compared to the $105.4 million recognized in the 2020 quarter. The increase is due primarily to the ongoing investment in our technology capabilities, including hosted solution licenses and depreciation, and higher office lease costs.

General, administrative, and other. General, administrative, and other expenses were $87.3 million in the first quarter of 2021, a decrease of $10.2 million, or 13.2%, compared to the $77.1 million recognized in the 2020 quarter. The timing of when certain general and administrative costs were incurred in the first quarter of 2021 compared to the 2020 period contributed to the higher costs. Lower travel-related expenses nearly offset increases in other general and administrative costs.

Non-operating income (loss)

Non-operating income for the first quarter of 2021 was $102.1 million, an increase of $602.4 million from non-operating loss of $500.3 million in the 2020 quarter. The following table details the components of non-operating income (loss) for both the first quarter of March 31, 2021 and 2020.

Page 24

	Three months ended
(in millions)	3/31/2021		3/31/2020
Net gains (losses) from non-consolidated T. Rowe Price investment products
Cash and discretionary investments
Dividend income	$	5.1	$	10.4
Market related gains (losses) and equity in earnings (losses)	8.6		(71.6)
Total cash and discretionary investments	13.7		(61.2)
Seed capital investments
Dividend income	.1		.7
Market related gains (losses) and equity in earnings (losses)	11.9		(34.1)
Net gain recognized upon deconsolidation	2.6		.1
Investments used to hedge the supplemental savings plan liability	22.1		(68.5)
Total net gains (losses) from non-consolidated T. Rowe Price investment products	50.4		(163.0)
Other investment income	18.2		8.4
Net gains (losses) on investments	68.6		(154.6)
Net gains (losses) on consolidated sponsored investment portfolios	37.2		(330.3)
Other income (loss), including foreign currency gains and losses	(3.7)		(15.4)
Non-operating income (loss)	$	102.1	$	(500.3)

The impact of strong market returns on our investment portfolio in the first quarter of 2021 compared with significant market losses in the first quarter of 2020 drove the increase in non-operating income. Our consolidated investment products and supplemental savings plan hedge portfolio comprised more than half of the net gains recognized during the first quarter of 2021. Our cash and discretionary investment portfolio also experienced net investment gains of $13.7 million in the first quarter of 2021.

The table above includes the net investment income of the underlying portfolios included in the consolidated T. Rowe Price investment products and not just the net investment income related to our interest. The table below shows the impact that the consolidated T. Rowe Price investment products had on the individual lines of our unaudited condensed consolidated statements of income and the portion attributable to our interest:

	Three months ended
(in millions)	3/31/2021		3/31/2020
Operating expenses reflected in net operating income	$	(3.5)	$	(3.7)
Net investment income (loss) reflected in non-operating income	37.2		(330.3)
Impact on income before taxes	$	33.7	$	(334.0)
Net income (loss) attributable to our interest in the consolidated T. Rowe Price investment products	$	18.3	$	(157.5)
Net income (loss) attributable to redeemable non-controlling interests (unrelated third-party investors)	15.4		(176.5)
	$	33.7	$	(334.0)

Provision for income taxes

Our effective tax rate for the first quarter of 2021 was 23.2%, compared with 19.5% in the 2020 quarter. The increase in our effective tax rate for the first quarter of 2021 as compared to the first quarter of 2020 is primarily due to lower discrete tax benefits associated with option exercises as well as the impact of these benefits relative to the higher pre-tax income in the first quarter of 2021 as compared to the comparable 2020 quarter. These benefits were partially offset by higher net gains attributable to redeemable non-controlling interests held in the firm's consolidated investment products, which are not taxable to the firm despite being included in pre-tax income, and a lower state effective tax rate. The state effective rate in the first quarter of 2020 was unfavorably impacted by the remeasurement of deferred state tax assets and liabilities related to our investment portfolio.

Page 25

The following table reconciles the statutory federal income tax rate to our effective tax rate for both the three months ended March 31, 2021 and 2020:

	Three months ended
	3/31/2021		3/31/2020
Statutory U.S. federal income tax rate	21.0	%	21.0	%
State income taxes for current year, net of federal income tax benefits(1)	3.8		6.4
Net (income) losses attributable to redeemable non-controlling interests	(.6)		3.1
Net excess tax benefits from stock-based compensation plans activity	(1.2)		(8.1)
Other items	.2		(2.9)
Effective income tax rate	23.2	%	19.5	%

(1) State income tax benefits are reflected in the total benefits for net income attributable to redeemable non-controlling interests and stock-based compensation plans activity.

Our effective tax rate will continue to experience volatility in future periods as the discrete tax benefits recognized from option exercises are impacted by market fluctuations in our stock price and timing of option exercises. The rate will also be impacted by net investment income recognized on our consolidated investment products that are driven by market fluctuations and changes in the proportion of their net income that is attributable to non-controlling interests.

The non-GAAP tax rate primarily adjusts for the impact of the consolidated investment products, including the net income attributable to the redeemable non-controlling interests. Our non-GAAP effective tax rate increased to 23.7% in the first quarter of 2021 compared with 22.5% in first quarter of 2020, primarily due to lower discrete tax benefits associated with option exercises in the first quarter of 2021 as well as the impact of these benefits relative to the higher pre-tax income in the first quarter of 2021 as compared to the comparable 2020 quarter and a lower effective state tax rate. The firm continues to see the phased-in benefit of the 2018 Maryland state tax legislation in which we expect to reduce our effective state rate over the five-year phase-in period to less than 3% by the end of 2022.

We currently estimate that our effective tax rate for the full year 2021, on a GAAP basis, will be in the range of 22% to 25%. On a non-GAAP basis, the range is 23% to 25%.

NON-GAAP INFORMATION AND RECONCILIATION.

We believe the non-GAAP financial measures below provide relevant and meaningful information to investors about our core operating results. These measures have been established in order to increase transparency for the purpose of evaluating our core business, for comparing current results with prior period results, and to enable more appropriate comparison with industry peers. However, non-GAAP financial measures should not be considered a substitute for financial measures calculated in accordance with U.S. GAAP and may be calculated differently by other companies.

The following schedules reconcile certain U.S. GAAP financial measures for the three months ended

March 31, 2021 and 2020.

	Three months ended 3/31/2021
	Operating expenses		Net operating income		Non-operating income (loss)		Provision (benefit) for income taxes(4)		Net income attributable to T. Rowe Price Group		Diluted earnings per share(5)
U.S. GAAP Basis	$	933.6	$	893.2	$	102.1	$	230.5	$	749.4	$	3.17
Non-GAAP adjustments:
Consolidated T. Rowe Price investment products(1)	(2.2)		3.5		(37.2)		(3.8)		(14.5)		(.06)
Supplemental savings plan liability(2)	(22.2)		22.2		(22.1)		—		.1		—
Other non-operating income(3)	—		—		(29.1)		(6.1)		(23.0)		(.10)
Adjusted Non-GAAP Basis	$	909.2	$	918.9	$	13.7	$	220.6	$	712.0	$	3.01

Page 26

	Three months ended 3/31/2020
	Operating expenses		Net operating income		Non-operating income (loss)		Provision (benefit) for income taxes(4)		Net income attributable to T. Rowe Price Group		Diluted earnings per share(5)
U.S. GAAP Basis	$	755.4	$	707.2	$	(500.3)	$	40.3	$	343.1	$	1.41
Non-GAAP adjustments:
Consolidated T. Rowe Price investment products(1)	(1.2)		3.7		330.3		71.1		86.4		.36
Supplemental savings plan liability(2)	63.7		(63.7)		68.5		2.1		2.7		.01
Other non-operating income(3)	—		—		40.3		18.2		22.1		.09
Adjusted Non-GAAP Basis	$	817.9	$	647.2	$	(61.2)	$	131.7	$	454.3	$	1.87

(1)    These non-GAAP adjustments remove the impact that the consolidated T. Rowe Price investment products have on our U.S. GAAP consolidated statements of income. Specifically, we add back the operating expenses and subtract the investment income of the consolidated T. Rowe Price investment products. The adjustment to our operating expenses represents the operating expenses of the consolidated products, net of the elimination of related management and administrative fees. The adjustment to net income attributable to T. Rowe Price Group represents the net income of the consolidated products, net of redeemable non-controlling interest. We remove the impact of the consolidated T. Rowe Price investment products as we believe they impact the reader’s ability to understand our core operating results.

(2)    These non-GAAP adjustments remove the compensation expense impact from market valuation changes in the supplemental savings plan liability and the related net gains (losses) on investments designated as an economic hedge against the related liability. Amounts deferred under the supplemental savings plan are adjusted for appreciation (depreciation) of hypothetical investments chosen by participants. We use T. Rowe Price investment products to economically hedge the exposure to these market movements. We believe it is useful to offset the non-operating investment income (loss) realized on the economic hedges against the related compensation expense and remove the net impact to help the reader's ability to understand our core operating results and to increase comparability period to period.

(3)    This non-GAAP adjustment represents the other non-operating income (loss) and the net gains (losses) earned on our non-consolidated investment portfolio that are not designated as economic hedges of the supplemental savings plan liability, and non-consolidated seed investments and other investments that are not part of the cash and discretionary investment portfolio. We retain the investment gains recognized on our non-consolidated cash and discretionary investments as these assets and related income (loss) are considered part of our core operations. We believe adjusting for these non-operating income (loss) items helps the reader’s ability to understand our core operating results and increases comparability to prior years. Additionally, we do not emphasize the impact of the portion of non-operating income (loss) removed when managing and evaluating our core performance.

(4)    The income tax impacts were calculated in order to achieve an overall non-GAAP effective tax rate of 23.7% for 2021 and 22.5% for 2020. We estimate that our effective tax rate for the full-year 2021 on a non-GAAP basis will be in the range of 23% to 25%.

(5)    This non-GAAP measure was calculated by applying the two-class method to adjusted net income attributable to T. Rowe Price Group divided by the weighted-average common shares outstanding assuming dilution. The calculation of adjusted net income allocated to common stockholders is as follows:

	Three months ended
	3/31/2021		3/31/2020
Adjusted net income attributable to T. Rowe Price Group	$	712.0	$	454.3
Less: adjusted net income allocated to outstanding restricted stock and stock unit holders	18.9		12.4
Adjusted net income allocated to common stockholders	$	693.1	$	441.9

Page 27

CAPITAL RESOURCES AND LIQUIDITY.

Sources of Liquidity

We remain debt-free with ample liquidity, including cash and investments in T. Rowe Price products, as follows:

(in millions)	3/31/2021		12/31/2020
Cash and cash equivalents	$	2,830.1	$	2,151.7
Discretionary investments	2,019.2		2,095.7
Total cash and discretionary investments	4,849.3		4,247.4
Redeemable seed capital investments	1,244.3		1,219.1
Investments used to hedge the supplemental savings plan liability	766.9		768.1
Total cash and investments in T. Rowe Price products	$	6,860.5	$	6,234.6

Our discretionary investment portfolio is comprised primarily of short duration bond funds, which typically yield higher than money market rates, and asset allocation products. Cash and discretionary investments returned gains of $13.7 million in the three months ended March 31, 2021, as compared to investment losses of $61.2 million in the three months ended March 31, 2020. Cash and discretionary investments in T. Rowe Price products held by our subsidiaries outside the United States were $754.4 million at March 31, 2021 and $675.8 million at December 31, 2020. Given the availability of our financial resources and cash expected to be generated through future operations, we do not maintain an available external source of additional liquidity.

Our seed capital investments are redeemable, although we generally expect to be invested for several years for the products to build an investment performance history and until unrelated third-party investors substantially reduce our relative ownership percentage.

The cash and investment presentation on the unaudited condensed consolidated balance sheet is based on the accounting treatment for the cash equivalent or investment item. The following table details how T. Rowe Price Group’s interests in cash and investments relate to where they are presented on the unaudited condensed consolidated balance sheet as of March 31, 2021.

(in millions)	Cash and cash equivalents		Investments		Net assets of consolidated T. Rowe Price investment products(1)		3/31/2021
Cash and discretionary investments	$	2,830.1	$	1,910.1	$	109.1	$	4,849.3
Seed capital investments	—		473.2		771.1		1,244.3
Investments used to hedge the supplemental savings plan liability	—		766.9		—		766.9
Total cash and investments in T. Rowe Price products attributable to T. Rowe Price Group	2,830.1		3,150.2		880.2		6,860.5
Investment in UTI and other investments	—		253.4		—		253.4
Total cash and investments attributable to T. Rowe Price Group	2,830.1		3,403.6		880.2		7,113.9
Redeemable non-controlling interests	—		—		1,012.9		1,012.9
As reported on unaudited condensed consolidated balance sheet at March 31, 2021	$	2,830.1	$	3,403.6	$	1,893.1	$	8,126.8

(1) The consolidated T. Rowe Price investment products are generally those products we provided seed capital at the time of their formation and we have a controlling interest. These products generally represent U.S. mutual funds as well as those funds regulated outside the U.S.     The $109.1 million and the $771.1 million represent the total value at March 31, 2021 of our interest in the consolidated T. Rowe Price investment products. The total net assets of the T. Rowe Price investment products at March 31, 2021 of $1,893.1 million includes assets of $1,946.8 million, less liabilities of $53.7 million as reflected in our unaudited condensed consolidated balance sheets.

Our unaudited condensed consolidated balance sheet reflects the cash and cash equivalents, investments, other assets and liabilities of those T. Rowe Price investment products we consolidate, as well as redeemable non-controlling interests for the portion of these T. Rowe Price investment products that are held by unrelated third-party investors. Although we can redeem our net interest in these T. Rowe Price investment products at any time, we

Page 28

cannot directly access or sell the assets held by the products to obtain cash for general operations. Additionally, the assets of these T. Rowe Price investment products are not available to our general creditors. Our interest in these

T. Rowe Price investment products was used as initial seed capital and is recategorized as discretionary when it is determined by management that the seed capital is no longer needed. We assess the discretionary investment products and, when we decide to liquidate our interest, we seek to do so in a way as to not impact the product and, ultimately, the unrelated third-party investors.

Uses of Liquidity

We increased our quarterly recurring dividend per common share in February 2021 by 20.0% to $1.08 per common share from $.90 per common share. Additionally, we expended $.3 billion in the first quarter of 2021 to repurchase 1.6 million shares, or 0.7%, of our outstanding common stock at an average price of $164.22 per share. These dividends and repurchases were expended using existing cash balances and cash generated from operations. While opportunistic in our approach to stock buybacks, we will generally repurchase our common stock over time to offset the dilution created by our equity-based compensation plans.

Since the end of 2018, we have returned $4.0 billion to stockholders through stock repurchases and our regular quarterly dividends, as follows:

(in millions)	Recurring dividend		Stock repurchases		Total cash returned to stockholders
2019	$	733.6	$	708.8	$	1,442.4
2020	846.0		1,192.2		2,038.2
Three months ended 3/31/2021	252.3		267.6		519.9
Total	$	1,831.9	$	2,168.6	$	4,000.5

We anticipate property, equipment and other capital expenditures, including internal labor capitalization, for the full-year 2021 to be about $265 million, of which more than three-quarters is planned for technology initiatives. We expect to fund our anticipated capital expenditures with operating cash flows and other available resources.

Page 29

Cash Flows

The following table summarizes the cash flows for the three months ended March 31, 2021 and 2020, that are attributable to T. Rowe Price Group, our consolidated T. Rowe Price investment products, and the related eliminations required in preparing the statement.

	Three months ended
	3/31/2021								3/31/2020
(in millions)	Cash flow attributable to T. Rowe Price Group		Cash flow attributable to consolidated T. Rowe Price investment products		Elims		As reported		Cash flow attributable to T. Rowe Price Group		Cash flow attributable to consolidated T. Rowe Price investment products		Elims		As reported
Cash flows from operating activities
Net income	$	749.4	$	33.7	$	(18.3)	$	764.8	$	343.1	$	(334.0)	$	157.5	$	166.6
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization of property and equipment	49.0		—		—		49.0		46.1		—		—		46.1
Stock-based compensation expense	57.5		—		—		57.5		58.3		—		—		58.3
Net (gains) losses recognized on investments	(77.8)		—		18.3		(59.5)		324.8		—		(157.5)		167.3
Net change in T. Rowe Price investment products used to economically hedge supplemental savings plan liability	22.0		—		—		22.0		(8.9)		—		—		(8.9)
Net change in trading securities held by consolidated T. Rowe Price investment products	—		(120.9)		—		(120.9)		—		234.6		—		234.6
Other changes in assets and liabilities	338.5		(56.5)		(.2)		281.8		100.6		23.7		(.6)		123.7
Net cash provided by (used in) operating activities	1,138.6		(143.7)		(.2)		994.7		864.0		(75.7)		(.6)		787.7
Net cash provided by (used in) investing activities	30.4		(27.3)		(33.9)		(30.8)		(15.0)		(.8)		43.4		27.6
Net cash provided by (used in) financing activities	(490.6)		149.0		34.1		(307.5)		(1,068.4)		118.9		(42.8)		(992.3)
Effect of exchange rate changes on cash and cash equivalents of consolidated T. Rowe Price investment products	—		.9		—		.9		—		(1.2)		—		(1.2)
Net change in cash and cash equivalents during period	678.4		(21.1)		—		657.3		(219.4)		41.2		—		(178.2)
Cash and cash equivalents at beginning of year	2,151.7		104.8		—		2,256.5		1,781.8		76.5		—		1,858.3
Cash and cash equivalents at end of period	$	2,830.1	$	83.7	$	—	$	2,913.8	$	1,562.4	$	117.7	$	—	$	1,680.1

Page 30

Operating Activities

Operating activities attributable to T. Rowe Price Group during the first quarter of 2021 provided cash flows of $1,138.6 million as compared to $864.0 million during the first quarter of 2020. Operating cash flows attributable to T. Rowe Price Group increased $274.6 million, including a $406.3 million increase in net income from the first quarter of 2020 and timing differences on the cash settlement of our assets and liabilities of $237.9 million. These increases were partially offset by $400.5 million in lower non-cash adjustments, including unrealized investment gains/losses, depreciation, and stock-based compensation expense. The non-cash adjustments were primarily driven by a $402.6 million increase in net investment gains in the first quarter of 2021 compared with net investment losses in the first quarter of 2020. Additionally, in 2021, we had net proceeds of $22.0 million from certain investment products that economically hedge our supplemental savings plan liability, while we had net investments of $8.9 million in the same period of 2020. Our interim operating cash flows do not include the cash impact of variable compensation that is accrued throughout the year before being substantially paid out in December. The remaining change in reported cash flows from operating activities was attributable to the net change in trading securities held in our consolidated investment products’ underlying portfolios.

Investing Activities

Net cash provided by investing activities that are attributable to T. Rowe Price Group totaled $30.4 million in the first quarter of 2021 compared with $15.0 million of cash used by investing activities in the 2020 period. During 2021, we decreased the level of seed capital provided by $77.3 million. We eliminate our seed capital in those T. Rowe Price investment products we consolidate in preparing our unaudited condensed consolidated statement of cash flows. Partially offsetting this increase to cash provided by investing activities were lower net proceeds from the sale of certain of our discretionary investments of $47.8 million compared to net proceeds of $74.0 million during 2020. In addition, we increased our property and equipment expenditures by $12.8 million. The remaining $26.5 million change in reported cash flows from investing activities is related to the net cash removed from our balance sheet from consolidating and deconsolidating investment products.

Financing Activities

Net cash used in financing activities attributable to T. Rowe Price Group were $490.6 million in the first quarter of 2021 compared with $1,068.4 million in the 2020 period. During 2021, there was a $632.1 million decrease in cash paid for common stock repurchases as we repurchased 6.7 million less shares of common stock in the first quarter of 2021 as compared to the first quarter of 2020. Partially offsetting this decrease in cash used for financing activities was a $37.1 million increase in dividends paid in 2021 as a result of an 20.0% increase in our quarterly dividend per share. The remaining change in reported cash flows from financing activities is primarily attributable to a $107.0 million increase in net subscriptions received from redeemable non-controlling interest holders of our consolidated investment products during the first quarter of 2021 compared to the 2020 period.

CRITICAL ACCOUNTING POLICIES.

The preparation of financial statements often requires the selection of specific accounting methods and policies from among several acceptable alternatives. Further, significant estimates and judgments may be required in selecting and applying those methods and policies in the recognition of the assets and liabilities in our unaudited condensed consolidated balance sheets, the revenues and expenses in our unaudited condensed consolidated statements of income, and the information that is contained in our significant accounting policies and notes to unaudited condensed consolidated financial statements. Making these estimates and judgments requires the analysis of information concerning events that may not yet be complete and of facts and circumstances that may change over time. Accordingly, actual amounts or future results can differ materially from those estimates that we include currently in our unaudited condensed consolidated financial statements, significant accounting policies, and notes.

There have been no material changes in the critical accounting policies previously identified in our 2020 Annual Report on Form 10-K.

NEWLY-ISSUED BUT NOT YET ADOPTED ACCOUNTING GUIDANCE.

See Note 1 - The Company and Basis of Preparation note within Item 1. Financial Statements for a discussion of newly issued but not yet adopted accounting guidance.

Page 31

FORWARD-LOOKING INFORMATION.

From time to time, information or statements provided by or on behalf of T. Rowe Price, including those within this report, may contain certain forward-looking information, including information or anticipated information relating to: our revenues, net income, and earnings per share on common stock; changes in the amount and composition of our assets under management; our expense levels; our tax rate; and our expectations regarding financial markets, future transactions, dividends, stock repurchases, investments, new products and services, capital expenditures, changes in our effective fee rate, the impact of the coronavirus pandemic, and other market conditions. Readers are cautioned that any forward-looking information provided by or on behalf of T. Rowe Price is not a guarantee of future performance. Actual results may differ materially from those in forward-looking information because of various factors including, but not limited to, those discussed below and in Item 1A, Risk Factors, included in our Form 10-K Annual Report for 2020. Further, forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which it is made or to reflect the occurrence of unanticipated events.

Our future revenues and results of operations will fluctuate primarily due to changes in the total value and composition of assets under our management. Such changes result from many factors, including, among other things: cash inflows and outflows in the U.S. mutual funds, subadvised funds, separately managed accounts, collective investment trusts, and other investment products, fluctuations in global financial markets that result in appreciation or depreciation of the assets under our management, our introduction of new mutual funds and investment products, changes in retirement savings trends relative to participant-directed investments and defined contribution plans, and the impact of the coronavirus outbreak. The ability to attract and retain investors’ assets under our management is dependent on investor sentiment and confidence; the relative investment performance of the U.S. mutual funds and other managed investment products as compared with competing offerings and market indexes; the ability to maintain our investment management and administrative fees at appropriate levels; competitive conditions in the mutual fund, asset management, and broader financial services sectors; and our level of success in implementing our strategy to expand our business, including our announced plan to establish T. Rowe Price Investment Management as a separate registered investment adviser. Our revenues are substantially dependent on fees earned under contracts with the T. Rowe Price funds and could be adversely affected if the independent directors of one or more of the T. Rowe Price funds terminated or significantly altered the terms of the investment management or related administrative services agreements. Non-operating investment income will also fluctuate primarily due to the size of our investments, changes in their market valuations, and any other-than-temporary impairments that may arise or, in the case of our equity method investments, our proportionate share of the investees' net income.

Our future results are also dependent upon the level of our expenses, which are subject to fluctuation for the following or other reasons: changes in the level of our advertising and promotion expenses in response to market conditions, including our efforts to expand our investment advisory business to investors outside the U.S. and to further penetrate our distribution channels within the U.S.; the pace and level of spending to support key strategic priorities; variations in the level of total compensation expense due to, among other things, bonuses, restricted stock units and other equity grants, other incentive awards, our supplemental savings plan, changes in our employee count and mix, and competitive factors; any goodwill or other asset impairment that may arise; fluctuation in foreign currency exchange rates applicable to the costs of our international operations; expenses and capital costs, such as technology assets, depreciation, amortization, and research and development, incurred to maintain and enhance our administrative and operating services infrastructure; the level of third party research costs, unanticipated costs that may be incurred to protect investor accounts and the goodwill of our clients; and disruptions of services, including those provided by third parties, such as fund and product recordkeeping, facilities, communications, power, and the mutual fund transfer agent and accounting systems.

Our business is also subject to substantial governmental regulation, and changes in legal, regulatory, accounting, tax, and compliance requirements may have a substantial effect on our operations and results, including, but not limited to, effects on costs that we incur and effects on investor interest in T. Rowe Price investment products and investing in general or in particular classes of mutual funds or other investments.

Page 32

Item 3.Quantitative and Qualitative Disclosures About Market Risk.

There has been no material change in the total potential loss information provided in Item 7A of the Form 10-K Annual Report for 2020.

Item 4.Controls and Procedures.

Our management, including our principal executive and principal financial officers, has evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2021. Based on that evaluation, our principal executive and principal financial officers have concluded that our disclosure controls and procedures as of March 31, 2021, are effective at the reasonable assurance level to ensure that the information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, including this Form 10-Q quarterly report, is recorded, processed, summarized, and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms, and to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Our management, including our principal executive and principal financial officers, has evaluated any change in our internal control over financial reporting that occurred during the first quarter of 2021, and has concluded that there was no change during the first quarter of 2021 that have materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1. Legal Proceedings.

For information about our legal proceedings, please see our Commitments and Contingencies footnote to our unaudited condensed consolidated financial statements in Part 1. of this Form 10-Q.

Item 1A. Risk Factors.

There have been no material changes in the information provided in Item 1A of our Form 10-K Annual Report for 2020.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

(c) Repurchase activity during the first quarter of 2021 is as follows:

Month	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Program	Maximum Number of Shares that May Yet Be Purchased Under the Program
January	178,193	$	151.29	142,551	21,324,760
February	864,525	$	161.23	799,129	20,525,631
March	715,743	$	170.76	687,784	19,837,847
Total	1,758,461	$	164.10	1,629,464

Shares repurchased by us in a quarter may include repurchases conducted pursuant to publicly announced board authorization, outstanding shares surrendered to the company to pay the exercise price in connection with swap exercises of employee stock options, and shares withheld to cover the minimum tax withholding obligation associated with the vesting of restricted stock awards. Of the total number of shares purchased during the first quarter of 2021, 128,997 were related to shares surrendered in connection with employee stock option exercises and no shares were withheld to cover tax withholdings associated with the vesting of restricted stock awards.

Page 33

The following table details the changes in and status of the Board of Directors’ outstanding publicly announced board authorizations.

Authorization Dates	1/1/2021	Total Number of Shares Purchased	Maximum Number of Shares that May Yet Be Purchased at 3/31/2021
February 2019	6,467,311	(1,629,464)	4,837,847
March 2020	15,000,000	—	15,000,000
	21,467,311	(1,629,464)	19,837,847

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5.Other Information.

On April 29, 2021, we issued an earnings release reporting our results of operations for the first quarter of 2021. A copy of that earnings release is furnished herewith as Exhibit 99.1. This information shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.

Item 6. Exhibits.

The following exhibits required by Item 601 of Regulation S-K are furnished herewith.

3(i)	Charter of T. Rowe Price Group, Inc., as reflected by Articles of Restatement dated June 20, 2018. (Incorporated by reference from Form 10-Q Quarterly Report filed on July 25, 2018.)
3(ii)	Amended and Restated By-Laws of T. Rowe Price Group, Inc. as of February 9, 2021. (Incorporated by reference from Form 10-K Annual Report filed on February 11, 2021.)
15	Report from KPMG LLP, independent registered public accounting firm, re unaudited interim financial information.
31(i).1	Rule 13a-14(a) Certification of Principal Executive Officer.
31(i).2	Rule 13a-14(a) Certification of Principal Financial Officer.
32	Section 1350 Certifications.
99.1	Earnings release issued April 29, 2021, reporting our results of operations for the first quarter of 2021.
101	The following series of unaudited XBRL-formatted documents are collectively included herewith as Exhibit 101. The financial information is extracted from T. Rowe Price Group’s unaudited condensed consolidated interim financial statements and notes that are included in this Form 10-Q Report.
101.INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Calculation Linkbase Document
101.LAB	XBRL Taxonomy Label Linkbase Document
101.PRE	XBRL Taxonomy Presentation Linkbase Document
101.DEF	XBRL Taxonomy Definition Linkbase Document

Page 34

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on April 29, 2021.

T. Rowe Price Group, Inc.

By:    /s/ Céline S. Dufétel

        Vice President, Chief Operating Officer, Chief Financial Officer and Treasurer

Page 35

EX-15

EXHIBIT 15                 Letter from KPMG LLP, independent registered public accounting firm,

                                   re unaudited interim financial information

April 29, 2021

T. Rowe Price Group, Inc.

Baltimore, Maryland

Re: Registration Statements No. 33-7012, No. 333-59714, No. 333-120882, No. 333-120883, No. 333-142092, No. 333-167317, No. 333-180904, No. 333-199560, No. 333-212705 , No. 333-217483, and No. 333-238319.

With respect to the subject registration statements, we acknowledge our awareness of the use therein of our report dated April 29, 2021 related to our review of interim financial information.

Pursuant to Rule 436 under the Securities Act of 1933 (the Act), such report is not considered part of a registration statement prepared or certified by an independent registered public accounting firm, or a report prepared or certified by an independent registered public accounting firm within the meaning of Sections 7 and 11 of the Act.

/s/ KPMG LLP

Baltimore, Maryland

EX-31.1

EXHIBIT 31(i).1                     Rule 13a-14(a) Certification of Principal Executive Officer

I, William J. Stromberg, certify that:

1.I have reviewed this Form 10-Q Quarterly Report for the quarterly period ended March 31, 2021 of T. Rowe Price Group, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

April 29, 2021

/s/ William J. Stromberg

Chief Executive Officer and Chairman of the Board of Directors

EX-31.2

EXHIBIT 31(i).2                      Rule 13a-14(a) Certification of Principal Financial Officer

I, Céline S. Dufétel, certify that:

1.I have reviewed this Form 10-Q Quarterly Report for the quarterly period ended March 31, 2021 of T. Rowe Price Group, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

April 29, 2021

/s/ Céline S. Dufétel

Vice President, Chief Operating Officer, Chief Financial Officer and Treasurer

EX-32

EXHIBIT 32                                     Section 1350 Certifications    

We certify, to the best of our knowledge, based upon a review of the Form 10-Q Quarterly Report for the quarterly period ended March 31, 2021, of T. Rowe Price Group, Inc., that:

(1) The Form 10-Q Quarterly Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Form 10-Q Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of T. Rowe Price Group, Inc.

April 29, 2021

/s/ William J. Stromberg

Chief Executive Officer and Chairman of the Board of Directors

/s/ Céline S. Dufétel

Vice President, Chief Operating Officer, Chief Financial Officer and Treasurer

EX-99.1

NEWS RELEASE

T. ROWE PRICE GROUP REPORTS FIRST QUARTER 2021 RESULTS

BALTIMORE (April 29, 2021) - T. Rowe Price Group, Inc. (NASDAQ-GS: TROW) today reported its results for the first quarter of 2021.

▪Assets under management end quarter at $1.52 trillion

▪Net client inflows of $1.2 billion for Q1 2021

▪Net revenues of $1.8 billion for Q1 2021

▪Diluted earnings per common share of$3.17 for Q1 2021

▪Adjusted non-GAAP diluted earnings per common share of $3.01 for Q1 2021

▪Long-term investment performance remains strong

Financial Highlights

	Three Months ended
(in millions, except per-share data)	3/31/2021		3/31/2020		% change		12/31/2020		% change
U.S. GAAP basis
Investment advisory fees	$	1,687.8	$	1,327.8	27.1	%	$	1,602.2	5.3	%
Net revenues	$	1,826.8	$	1,462.6	24.9	%	$	1,732.9	5.4	%
Operating expenses	$	933.6	$	755.4	23.6	%	$	977.0	(4.4)	%
Net operating income	$	893.2	$	707.2	26.3	%	$	755.9	18.2	%
Non-operating income (loss)(1)	$	102.1	$	(500.3)	n/m		$	390.1	n/m
Net income attributable to T. Rowe Price Group	$	749.4	$	343.1	118.4	%	$	783.4	(4.3)	%
Diluted earnings per common share	$	3.17	$	1.41	124.8	%	$	3.33	(4.8)	%
Weighted average common shares outstanding assuming dilution	230.0		236.8		(2.9)	%	229.2		.3	%
Adjusted non-GAAP basis(2)
Operating expenses	$	909.2	$	817.9	11.2	%	$	908.5	.1	%
Net operating income	$	918.9	$	647.2	42.0	%	$	827.0	11.1	%
Non-operating income (loss)(1)	$	13.7	$	(61.2)	n/m		$	42.5	n/m
Net income attributable to T. Rowe Price Group	$	712.0	$	454.3	56.7	%	$	680.2	4.7	%
Diluted earnings per common share	$	3.01	$	1.87	61.0	%	$	2.89	4.2	%
Assets under Management(in billions)
Average assets under management	$	1,508.8	$	1,162.7	29.8	%	$	1,394.0	8.2	%
Ending assets under management	$	1,518.0	$	1,008.8	50.5	%	$	1,470.5	3.2	%

(1) The percentage change in non-operating income is not meaningful (n/m).

(2) Adjusts the GAAP basis for the impact of consolidated T. Rowe Price investment products, the impact of market movements on the supplemental savings plan liability and related economic hedges, investment income related to certain other investments, and certain nonrecurring charges and gains, if any. The firm believes the non-GAAP financial measures provide relevant and meaningful information to investors about its core operating results. See the reconciliation to the comparable U.S. GAAP measures at the end of this earnings release.

1

Management Commentary

William J. Stromberg, chief executive officer, commented: “The first quarter of 2021 saw stocks in developed markets generate strong returns lifted by the accelerating rollout of coronavirus vaccines, ongoing monetary stimulus, and expectations for a new U.S. federal fiscal stimulus package. Small- and mid-cap stocks outpaced larger caps while cyclically oriented value stocks outperformed growth stocks. In bond markets, rising interest rates led to mixed results. T. Rowe Price’s long-term investment performance remained strong particularly across our asset allocation products.

“With continued strong equity markets, our revenues rose 25% and our net operating income increased 26% vs Q1 2020, leading to EPS of $3.17. These robust financials allowed us to push ahead with execution of our strategic initiatives. Highlights in the first quarter included:

•Positive flows of $1.2 billion for the first quarter were led by $4.5 billion of net flows into our target date products, as we saw retirement savers return to more typical levels of contributions and withdrawals versus last year. Our APAC and EMEA intermediary businesses continued to deliver healthy positive flows for the quarter. However, some institutional clients harvested the market gains in U.S. large-cap growth equities of 2020, which was a headwind to net flows.

•We expanded our ESG product range with the launch of the T. Rowe Price Global Impact Equity Fund, our first fund with the dual goals of providing excess returns over its benchmark while positively impacting the environment and social equity issues. We plan to extend this range of impact products which complement our already launched range of Responsible SICAVs and OEICs that use an exclusion approach. In addition, we launched a UK Equity strategy and a China Growth Opportunities strategy.

•We continued to make investments in support of the future growth of our APAC and EMEA businesses. We announced the relocation of our London office to a larger, more modern, and environmentally efficient building. Following the approval in December 2020 for our wholly foreign owned enterprise, T. Rowe Price Investment Consulting (Shanghai) Co, Ltd., we officially opened our Shanghai investment office in March 2021.

“Finally, I want to recognize our associates’ continued perseverance and resilience through this extended work from home environment. We look forward to being back in our global offices and seeing each other in person later this year.”

Assets Under Management

During Q1 2021, assets under management increased $47.5 billion to $1.52 trillion. Net cash inflows were

$1.2 billion, and clients transferred $5.6 billion in net assets from the U.S. mutual funds primarily to collective investment trusts and other investment products, of which $4.9 billion transferred into the retirement date trusts. The components of the change in assets under management, by vehicle and asset class, are shown in the tables below.

2

	Three months ended 3/31/2021
(in billions)	U.S. mutual funds		Subadvised funds and separate accounts		Collective investment trusts and other investment products		Total
Assets under management at beginning of period	$	794.6	$	400.1	$	275.8	$	1,470.5
Net cash flows before client transfers	2.0		(8.2)		7.4		1.2
Client transfers	(5.6)		—		5.6		—
Net cash flows after client transfers	(3.6)		(8.2)		13.0		1.2
Net market appreciation and gains	25.5		11.9		9.0		46.4
Net distributions not reinvested	(.1)		—		—		(.1)
Change during the period	21.8		3.7		22.0		47.5
Assets under management at March 31, 2021	$	816.4	$	403.8	$	297.8	$	1,518.0

	Three months ended 3/31/2021
(in billions)	Equity		Fixed income, including money market		Multi-asset(1)		Total
Assets under management at beginning of period	$	895.8	$	168.7	$	406.0	$	1,470.5
Net cash flows	(8.9)		5.4		4.7		1.2
Net market appreciation and gains(2)	30.3		(1.3)		17.3		46.3
Change during the period	21.4		4.1		22.0		47.5
Assets under management at March 31, 2021	$	917.2	$	172.8	$	428.0	$	1,518.0

(1) The underlying assets under management of the multi-asset portfolios have been aggregated and presented in this category and not reported in the equity and fixed income columns.

(2) Includes distributions not reinvested.

Assets under management in the firm's target date retirement products, which are reported as part of the multi-asset column in the table above, were $351.6 billion at March 31, 2021, compared with $332.2 billion at

December 31, 2020. Net cash flows into these portfolios were $4.5 billion in Q1 2021.

Investors domiciled outside the United States accounted for 8.8% of the firm's assets under management at March 31, 2021 and 9.3% at December 31, 2020.

The firm provides participant accounting and plan administration for defined contribution retirement plans that invest in the firm's U.S. mutual funds and collective investment trusts, as well as funds outside of the firm's complex. As of

March 31, 2021, the firm's assets under administration were $248 billion, of which nearly $153 billion are assets we manage.

In recent years, the firm began offering non-discretionary advisory services through model delivery, which are managed accounts where portfolio holdings and trades in the portfolio are provided to sponsor platforms to implement for their clients. The firm records the revenue earned on these services in administrative fees. The assets under advisement in these portfolios, predominantly in the United States, were $3 billion at March 31, 2021.

3

Financial Results

Net revenues earned in Q1 2021 were $1.8 billion, up 24.9% from Q1 2020. Average assets under management in Q1 2021 were $1.51 trillion, an increase of 29.8% from Q1 2020. The firm voluntarily waived money market advisory fees in Q1 2021 of $15.0 million to continue to maintain positive yields for investors. The firm expects to continue to waive fees for all of 2021 and anticipates that the waivers in each of the next three quarters of 2021 will be at similar levels.

▪Investment advisory revenues earned in Q1 2021 from the firm's U.S. mutual funds were $1.1 billion, an increase of 19.9% from Q1 2020. Average assets under management in these funds increased 24.5% to $814.5 billion in Q1 2021 from Q1 2020.

▪Investment advisory revenues earned in Q1 2021 from subadvised funds, separate accounts, collective investment trusts and other investment products were $637.6 million, an increase of 41.2% from Q1 2020. Average assets under management for these products increased 36.6% to $694.3 billion in Q1 2021 from Q1 2020.

▪The annualized effective fee rate of 45.4 basis points in Q1 2021 was down from 45.9 basis points earned in Q1 2020 and from 45.7 basis points earned in Q4 2020. In comparison to Q1 2020, the annualized effective fee rate decreased due to the impact of client transfers to lower fee vehicles or share classes within the complex over the last twelve months and money market fee waivers. In comparison to Q4 2020, the Q1 2021 annualized effective fee rate decreased primarily due to lower performance fees in Q1 2021. Over time, the firm's effective fee rate can be impacted by market or cash flow related shifts among asset and share classes, price changes in existing products, and asset level changes in products with tiered-fee structures.

▪Administrative, distribution, and servicing fees in Q1 2021 were $139.0 million, an increase of 3.1% from Q1 2020. The increase was primarily attributable to higher transfer agent servicing activities provided to the T. Rowe Price mutual funds, higher model delivery revenue, as well as higher 12b-1 revenue earned on the R share class of the U.S. mutual funds as a result of increased assets under management in this share class.

Operating expenses in Q1 2021 were $933.6 million, an increase of 23.6% compared to Q1 2020. Nearly half of the increase in the firm's operating expenses from Q1 2020 was due to an $85.9 million increase in expense related to the supplemental savings plan from higher market returns. The remaining increase was due primarily to higher compensation expenses as well as distribution and servicing costs. The expense related to the supplemental savings plan was almost entirely offset by the non-operating gains earned on the investments used to economically hedge the related liability.

4

On a non-GAAP basis, the firm's operating expenses in Q1 2021 were $909.2 million, an 11.2% increase over

Q1 2020. The firm's non-GAAP operating expenses do not include the impact of the supplemental savings plan and consolidated sponsored products.

▪Compensation and related costs were $583.5 million in Q1 2021, an increase of 32.4% compared to

Q1 2020. This increase was primarily related to $85.9 million in higher compensation expense related to the supplemental savings plan, as strong market returns in Q1 2021 increased the liability compared with the impact of market losses in Q1 2020, which decreased the liability. Also contributing to the increase in 2021 costs compared to Q1 2020, were a higher interim bonus accrual and higher salaries and benefits due to a 3.4% increase in our average staff size and modest increases in base salaries at the beginning of the year. The firm employed 7,697 associates at March 31, 2021, an increase of .2% from the end of 2020 and 3.0% from the end of Q1 2020.

▪Distribution and servicingcosts were $85.6 million in Q1 2021, an increase of 30.3% from

the $65.7 million recognized in Q1 2020. The increase was primarily driven by higher distribution costs as a result of continued inflows and market appreciation in the firm's international products, including the Japanese Investment Trusts (ITMs) and SICAVs. These distribution costs, like those related to certain shares classes of the U.S. mutual funds, are offset entirely in net revenues. For the ITMs and SICAVs, the related revenue is recognized in investment advisory revenues.

▪Advertising and promotion expenses were $18.9 million in Q1 2021, a decrease of 24.1% from Q1 2020. The decrease was primarily driven by the timing of media-related spend as well as fewer conference and promotional events since the later part of Q1 2020 due to the coronavirus pandemic.

▪Technology, occupancy, and facility costs were $117.3 million in Q1 2021, an increase of 11.3% from the $105.4 million recognized in Q1 2020. The increase was primarily due to the ongoing investment in the firm's technology capabilities, including hosted solution licenses and depreciation, and higher office lease costs.

▪General, administrative, and other costs were $87.3 million in Q1 2021, an increase of 13.2% compared with the $77.1 million recognized in Q1 2020. The timing of when certain general and administrative costs were incurred in Q1 2021 compared with Q1 2020 contributed to the higher costs. Lower travel-related expenses nearly offset increases in other general and administrative costs.

The firm updated its 2021 non-GAAP operating expense growth guidance from a range of 8%-12% to a range of 10%-14% to reflect an increase in the firm's expectations for AUM-related expenses. The firm could elect to further adjust its expense growth should unforeseen circumstances arise, including significant market movements.

5

Non-operating income (loss). Non-operating income was $102.1 million in Q1 2021, as compared to non-operating loss of $500.3 million in Q1 2020. The impact on the firm's investment portfolio of strong market returns in Q1 2021 compared with significant market losses in Q1 2021 drove the increase. For Q1 2021, the firm's consolidated investment products and supplemental savings plan hedge portfolio comprised more than half of the net gains recognized. The cash and discretionary investment portfolio added net investment gains of $13.7 million during Q1 2021. The components of non-operating income for Q1 2021 and Q1 2020 are included in the tables at the end of this release.

Income taxes. The firm's effective tax rate was 23.2% in Q1 2021 and 19.5% in Q1 2020. The following reconciles the statutory federal income tax rate to the firm's effective tax rate for the first quarter of 2021 and 2020:

	Three months ended
	3/31/2021		3/31/2020
Statutory U.S. federal income tax rate	21.0	%	21.0	%
State income taxes for current year, net of federal income tax benefits(1)	3.8		6.4
Net (income) losses attributable to redeemable non-controlling interests(2)	(.6)		3.1
Net excess tax benefits from stock-based compensation plans activity	(1.2)		(8.1)
Other items	.2		(2.9)
Effective income tax rate	23.2	%	19.5	%

(1) State income tax benefits are reflected in the total benefits for net income attributable to redeemable non-controlling interests and stock-based compensation plans activity.

(2) Net income attributable to redeemable non-controlling interest represents the portion of earnings held in the firm's consolidated investment products, which are not taxable to the firm despite being included in pre-tax income.

The firm's non-GAAP tax rate primarily adjusts for the impact of the consolidated investment products, including the net income attributable to the redeemable non-controlling interests. The firm's non-GAAP effective tax rate was 23.7% for Q1 2021. The rate was affected by lower discrete tax benefits associated with the settlement of stock-based awards as well as the impact of these benefits relative to the higher pre-tax income during the quarter, and a lower effective state tax rate as compared to Q1 2020. The firm continues to see the phased-in benefit of the 2018 Maryland state tax legislation in which we expect to reduce our effective state rate over the five-year phase-in period to less than 3% by the end of 2022.

The firm estimates that its effective tax rate for the full year 2021, on a GAAP basis, will be in the range of 22% to 25%. On a non-GAAP basis, the range is 23% to 25%.

6

Capital Management

T. Rowe Price remains debt-free with ample liquidity, including cash and investments in T. Rowe Price products as follows:

(in millions)	3/31/2021		12/31/2020
Cash and cash equivalents	$	2,830.1	$	2,151.7
Discretionary investments	2,019.2		2,095.7
Total cash and discretionary investments	4,849.3		4,247.4
Redeemable seed capital investments	1,244.3		1,219.1
Investments used to hedge the supplemental savings plan liability	766.9		768.1
Total cash and investments in T. Rowe Price products	$	6,860.5	$	6,234.6

▪The firm's common shares outstanding were 226.9 million at March 31, 2021, compared with 228.0 million at the end of 2020.

▪In Q1 2021, the firm expended $267.6 million to repurchase 1.6 million shares, or .7%, of its outstanding common shares at an average price of $164.22.

▪The firm invested $58.8 million during Q1 2021 in capitalized facilities and technology. The firm currently expects capital expenditures, including internal labor capitalization, for 2021 to be about $265 million, of which more than three-quarters is planned for technology initiatives. These expenditures are expected to continue to be funded from the firm's operating resources.

Investment Performance

The following table presents investment performance for specific asset classes and AUM-weighted performance, mutual fund performance against passive peers, and composite performance against benchmarks for the one-, three-, five-, and 10-years ended March 31, 2021. Past performance is no guarantee of future results.

% of U.S. mutual funds that outperformed Morningstar median(1),(2)
	1 year	3 years	5 years	10 years
Equity	65%	68%	67%	87%
Fixed Income	71%	60%	55%	57%
Multi-Asset	94%	94%	91%	90%
All Funds	75%	73%	70%	78%
% of U.S. mutual funds that outperformed passive peer median(1),(3)
	1 year	3 years	5 years	10 years
Equity	57%	58%	62%	72%
Fixed Income	91%	59%	57%	60%
Multi-Asset	94%	91%	87%	86%
All Funds	78%	68%	68%	72%
% of composites that outperformed benchmarks(4)
	1 year	3 years	5 years	10 years
Equity	55%	60%	73%	78%
Fixed Income	87%	69%	80%	72%
All Composites	68%	63%	76%	76%

7

AUM- Weighted Performance
% of U.S. mutual funds AUM that outperformed Morningstar median(1),(2)
	1 year	3 years	5 years	10 years
Equity	63%	65%	83%	94%
Fixed Income	79%	58%	59%	60%
Multi-Asset	100%	96%	96%	96%
All Funds	73%	72%	84%	92%
% of U.S. mutual funds AUM that outperformed passive peer median(1),(3)
	1 year	3 years	5 years	10 years
Equity	51%	53%	81%	81%
Fixed Income	97%	52%	56%	64%
Multi-Asset	98%	96%	96%	96%
All Funds	66%	63%	83%	84%
% of composites AUM that outperformed benchmarks(4)
	1 year	3 years	5 years	10 years
Equity	51%	65%	72%	79%
Fixed Income	88%	54%	73%	72%
All Composites	57%	64%	73%	79%

As of March 31, 2021, 80 of 123 (65.0%) of the firm's rated U.S. mutual funds (across primary share classes) received an overall rating of 4 or 5 stars. By comparison, 32.5% of Morningstar's fund population is given a rate of 4 or 5 stars(5). In addition, 88%(5) of AUM in the firm's rated U.S. mutual funds (across primary share classes) ended March 31, 2021 with an overall rating of 4 or 5 stars.

(1) Source: © 2021 Morningstar, Inc. All rights reserved. The information contained herein: 1) is proprietary to Morningstar and/or its content providers; 2) may not be copied or distributed; and 3) is not warranted to be accurate, complete, or timely.Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

(2)Source: Morningstar. Primary share class only. Excludes money market mutual funds, funds with an operating history of less than one year, T. Rowe Price passive funds, and T. Rowe Price funds that are clones of other funds. The top chart reflects the percentage of T. Rowe Price funds with 1 year, 3 year, 5 year, and 10 year track record that are outperforming the Morningstar category median. The bottom chart reflects the percentage of T. Rowe Price funds AUM that has outperformed for the time periods indicated. Total Fund AUM included for this analysis includes $503B for 1 year, $503B for 3 years, $503B for 5 years, and $493B for 10 years.

(3) Passive Peer Median was created by T. Rowe Price using data from Morningstar. Primary share class only. Excludes money market mutual funds, funds with an operating history of less than one year, funds with fewer than three peers, T. Rowe Price passive funds, and T. Rowe Price funds that are clones of other funds. This analysis compares T. Rowe Price active funds to the applicable universe of passive/index open-end funds and ETFs of peer firms. The top chart reflects the percentage of T. Rowe Price funds with 1 year, 3 year, 5 year, and 10 year track record that are outperforming the passive peer universe. The bottom chart reflects the percentage of T. Rowe Price funds AUM that has outperformed for the time periods indicated. Total AUM included for this analysis includes $491B for 1 year, $482B for 3 years, $439B for 5 years, and $416B for 10 years.

(4)Composite net returns are calculated using the highest applicable separate account fee schedule. Excludes money market composites. All composites compared to official GIPS composite primary benchmark. The top chart reflects the percentage of T. Rowe Price composites with 1 year, 3 year, 5 year, and 10 year track record that are outperforming their benchmarks. The bottom chart reflects the percentage of T. Rowe Price composite AUM that has outperformed for the time periods indicated. Total AUM included for this analysis includes $1,392B for 1 year, $1,388B for 3 years, $1,364B for 5 years, and $1,316B for 10 years.

(5) The Morningstar Rating™ for funds is calculated for funds with at least a three-year history. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. Morningstar gives its best ratings of 5 or 4 stars to the top 32.5% of all funds (of the 32.5%,10% get 5 stars and 22.5% get 4 stars). The Overall Morningstar Rating™ is derived from a weighted average of the performance figures associated with a fund’s 3, 5, and 10 year (if applicable) Morningstar Rating™ metrics.

Other Matters

The financial results presented in this release are unaudited. The firm expects that it will file its Form 10-Q Quarterly Report for the first quarter of 2021 with the U.S. Securities and Exchange Commission later today. The Form 10-Q will include additional information on the firm's unaudited consolidated financial statements at March 31, 2021.

Certain statements in this earnings release may represent “forward-looking information,” including information relating to anticipated changes in revenues, net income and earnings per common share, anticipated changes in the amount and composition of assets under management, anticipated expense levels, estimated effective tax rates, and expectations regarding financial results, future transactions, new products and services, investments, capital expenditures, dividends, stock repurchases, changes in our effective fee rate, the impact of the coronavirus

8

pandemic, and other market conditions. For a discussion concerning risks and other factors that could affect future results, see the firm's 2020 Annual Report on Form 10-K.

Founded in 1937, Baltimore-based T. Rowe Price (troweprice.com) is a global investment management organization that provides a broad array of mutual funds, subadvisory services, and separate account management for individual and institutional investors, retirement plans, and financial intermediaries. The organization also offers a variety of sophisticated investment planning and guidance tools. T. Rowe Price's disciplined, risk-aware investment approach focuses on diversification, style consistency, and fundamental research.

The firm announced that it will hold its 2021 Investor Day on Wednesday, May 26, 2021 from 9:00 a.m. to 11:00 a.m. Eastern Standard Time. It will be a virtual event and registration will open soon on the firm's investor relations website at troweprice.gcs-web.com.

CONTACTS:

Public Relations	Investor Relations
Brian Lewbart	Linsley Carruth
410-345-2242	410-345-3717
brian.lewbart@troweprice.com	linsley.carruth@troweprice.com

9

Unaudited Consolidated Statements of Income
(in millions, except per-share amounts)
		Three months ended
Revenues		3/31/2021		3/31/2020		12/31/2020
	Investment advisory fees	$	1,687.8	$	1,327.8	$	1,602.2
	Administrative, distribution, and servicing fees	139.0		134.8		130.7
	Net revenues	1,826.8		1,462.6		1,732.9
Operating expenses
	Compensation and related costs	583.5		440.7		640.4
	Distribution and servicing	85.6		65.7		77.3
	Advertising and promotion	18.9		24.9		31.2
	Product-related costs	41.0		41.6		37.5
	Technology, occupancy, and facility costs	117.3		105.4		112.5
	General, administrative, and other	87.3		77.1		78.1
	Total operating expenses	933.6		755.4		977.0
Net operating income		893.2		707.2		755.9
Non-operating income (loss)
Net gains (losses) on investments		68.6		(154.6)		146.2
Net gains (losses) on consolidated investment products		37.2		(330.3)		238.3
Other income (loss)		(3.7)		(15.4)		5.6
Total non-operating income (loss)		102.1		(500.3)		390.1
Income before income taxes		995.3		206.9		1,146.0
Provision for income taxes		230.5		40.3		216.4
Net income		764.8		166.6		929.6
	Less: net income (loss) attributable to redeemable non-controlling interests	15.4		(176.5)		146.2
Net income attributable to T. Rowe Price Group		749.4		343.1		783.4
	Less: net income allocated to outstanding restricted stock and stock unit holders	19.9		9.4		21.2
Net income allocated to T. Rowe Price Group common stockholders		$	729.5	$	333.7	$	762.2
Earnings per share
	Basic	$	3.20	$	1.43	$	3.36
	Diluted	$	3.17	$	1.41	$	3.33
Weighted-average common shares
	Outstanding	227.7		234.1		226.8
	Outstanding assuming dilution	230.0		236.8		229.2

10

The following table presents investment advisory revenues for the three-month periods ended March 31, 2021 and 2020, including a separate break out of revenue earned from our multi-asset portfolios. Prior year amounts have been recast to conform with the current year presentation.

Investment Advisory Revenues (in millions)	Three months ended
	3/31/2021		3/31/2020
U.S. mutual funds
Equity	$	729.8	$	568.4
Fixed income, including money market	59.0		71.7
Multi-asset	261.4		236.1
	1,050.2		876.2
Subadvised funds, separate accounts, collective investment trusts, and other investment products
Equity	429.8		279.5
Fixed income, including money market	31.7		38.0
Multi-asset	176.1		134.1
	637.6		451.6
Total	$	1,687.8	$	1,327.8

Assets Under Management (in billions)	Average during
	Three months ended				As of
	3/31/2021		3/31/2020		3/31/2021		12/31/2020
U.S. mutual funds
Equity	$	509.6	$	388.3	$	511.7	$	498.6
Fixed income, including money market	82.3		75.7		82.6		79.4
Multi-asset	222.6		190.3		222.1		216.6
	814.5		654.3		816.4		794.6
Subadvised funds, separate accounts, collective investment trusts, and other investment products
Equity	418.9		277.5		405.5		397.2
Fixed income, including money market	80.2		81.3		90.2		89.3
Multi-asset	195.2		149.6		205.9		189.4
	694.3		508.4		701.6		675.9
Total	$	1,508.8	$	1,162.7	$	1,518.0	$	1,470.5

Net Cash Flows After Client Transfers (by investment vehicle and underlying asset class)	Three months ended
(in billions)	3/31/2021
U.S. mutual funds
Equity	$	(3.6)
Fixed income, including money market	3.6
Multi-asset	(3.6)
	(3.6)
Subadvised funds, separate accounts, collective investment trusts, and other investment products
Equity	(5.3)
Fixed income, including money market	1.8
Multi-asset	8.3
	4.8
Total net cash flows after client transfers	$	1.2

11

Non-Operating Income (Loss) (in millions)	Three months ended
	3/31/2021		3/31/2020
Net gains (losses) from non-consolidated T. Rowe Price investment products
Cash and discretionary investments
Dividend income	$	5.1	$	10.4
Market related gains (losses) and equity in earnings (losses)	8.6		(71.6)
Total net gains (losses) from cash and discretionary investments	13.7		(61.2)
Seed capital investments
Dividend income	.1		.7
Market related gains (losses) and equity in earnings (losses)	11.9		(34.1)
Net gain recognized upon deconsolidation	2.6		.1
Investments used to hedge the supplemental savings plan liability	22.1		(68.5)
Total net gains (losses) from non-consolidated T. Rowe Price investment products	50.4		(163.0)
Other investment income	18.2		8.4
Net gains (losses) on investments	68.6		(154.6)
Net gains (losses) on consolidated sponsored investment portfolios	37.2		(330.3)
Other income (loss), including foreign currency gains and losses	(3.7)		(15.4)
Non-operating income (loss)	$	102.1	$	(500.3)

Unaudited Condensed Consolidated Cash Flows Information (in millions)
	Three months ended
	3/31/2021						3/31/2020
	Cash flow attributable to T. Rowe Price Group		Cash flow attributable to consolidated T. Rowe Price investment products, net of eliminations		As reported on statement of cash flows		Cash flow attributable to T. Rowe Price Group		Cash flow attributable to consolidated T. Rowe Price investment products, net of eliminations		As reported on statement of cash flows
Cash provided by (used in) operating activities, including $57.5 of stock-based compensation expense and $49.0 of depreciation expense in 2021	$	1,138.6	$	(143.9)	$	994.7	$	864.0	$	(76.3)	$	787.7
Cash provided by (used in) investing activities, including $(58.8) for additions to property and equipment, $(12.5) of purchases and $60.3 of dispositions to T. Rowe Price investment products in 2021	30.4		(61.2)		(30.8)		(15.0)		42.6		27.6
Cash provided by (used in) financing activities, including T. Rowe Price Group common stock repurchases of $(259.2)* and dividends paid of $(252.3) in 2021	(490.6)		183.1		(307.5)		(1,068.4)		76.1		(992.3)
Effect of exchange rate changes on cash and cash equivalents	—		.9		.9		—		(1.2)		(1.2)
Net change in cash and cash equivalents during period	$	678.4	$	(21.1)	$	657.3	$	(219.4)	$	41.2	$	(178.2)

*Cash flows for stock repurchases reflect the impact of the timing of the settlement of these transactions at each period beginning and end.

12

Unaudited Condensed Consolidated Balance Sheet Information (in millions)	As of
	3/31/2021		12/31/2020
Cash and cash equivalents	$	2,830.1	$	2,151.7
Accounts receivable and accrued revenue	885.9		863.1
Investments	3,403.6		3,250.8
Assets of consolidated T. Rowe Price investment products	1,946.8		2,695.5
Operating lease assets	110.2		117.6
Property and equipment, net	703.9		695.4
Goodwill	665.7		665.7
Other assets	218.2		219.2
Total assets	10,764.4		10,659.0
Supplemental savings plan liability	769.9		772.2
Total other liabilities, includes $53.7 at March 31, 2021, and $57.7 at December 31, 2020, from consolidated T. Rowe Price investment products	973.4		618.1
Redeemable non-controlling interests	1,012.9		1,561.7
Stockholders' equity, 226.9 common shares outstanding at March 31, 2021 and 228.0 common shares outstanding at December 31, 2020	$	8,008.2	$	7,707.0

Cash, Cash Equivalents, and Investments Information (in millions)
	Cash and cash equivalents		Investments		Net assets of consolidated T. Rowe Price investment products*		Total
Cash and discretionary investments	$	2,830.1	$	1,910.1	$	109.1	$	4,849.3
Seed capital investments	—		473.2		771.1		1,244.3
Investments used to hedge the supplemental savings plan liability	—		766.9		—		766.9
Total cash and investments in T. Rowe Price products attributable to T. Rowe Price Group	2,830.1		3,150.2		880.2		6,860.5
Investment in UTI and other investments	—		253.4		—		253.4
Total cash and investments attributable to T. Rowe Price Group	2,830.1		3,403.6		880.2		7,113.9
Redeemable non-controlling interests	—		—		1,012.9		1,012.9
As reported on unaudited condensed consolidated balance sheet at March 31, 2021	$	2,830.1	$	3,403.6	$	1,893.1	$	8,126.8

* The $109.1 million and $771.1 million represent the total value at December 31, 2020, of T. Rowe Price's interest in the consolidated T. Rowe Price investment products. The total net assets of $1,893.1 million at March 31, 2021, includes assets of $1,946.8 million less liabilities of $53.7 million as reflected in the unaudited condensed consolidated balance sheet information table above.

13

Non-GAAP Information and Reconciliation

The firm believes the non-GAAP financial measures below provide relevant and meaningful information to investors about its core operating results. These measures have been established in order to increase transparency for the purpose of evaluating the firm's core business, for comparing current results with prior period results, and to enable more appropriate comparison with industry peers. However, non-GAAP financial measures should not be considered as a substitute for financial measures calculated in accordance with U.S. GAAP and may be calculated differently by other companies.

The following schedules reconcile U.S. GAAP financial measures to non-GAAP financial measures for the three months endedMarch 31, 2021 and 2020 and December 31, 2020.

	Three months ended 3/31/2021
	Operating expenses		Net operating income		Non-operating income (loss)		Provision (benefit) for income taxes(4)		Net income attributable to T. Rowe Price Group		Diluted earnings per share(5)
U.S. GAAP Basis	$	933.6	$	893.2	$	102.1	$	230.5	$	749.4	$	3.17
Non-GAAP adjustments:
Consolidated T. Rowe Price    investment products(1)	(2.2)		3.5		(37.2)		(3.8)		(14.5)		(.06)
Supplemental savings plan liability(2)	(22.2)		22.2		(22.1)		—		.1		—
Other non-operating income(3)	—		—		(29.1)		(6.1)		(23.0)		(.10)
Adjusted Non-GAAP Basis	$	909.2	$	918.9	$	13.7	$	220.6	$	712.0	$	3.01

	Three months ended 3/31/2020
	Operating expenses		Net operating income		Non-operating income (loss)		Provision (benefit) for income taxes(4)		Net income attributable to T. Rowe Price Group		Diluted earnings per share(5)
U.S. GAAP Basis	$	755.4	$	707.2	$	(500.3)	$	40.3	$	343.1	$	1.41
Non-GAAP adjustments:
Consolidated T. Rowe Price    investment products(1)	(1.2)		3.7		330.3		71.1		86.4		.36
Supplemental savings plan liability(2)	63.7		(63.7)		68.5		2.1		2.7		.01
Other non-operating income(3)	—		—		40.3		18.2		22.1		.09
Adjusted Non-GAAP Basis	$	817.9	$	647.2	$	(61.2)	$	131.7	$	454.3	$	1.87

	Three months ended 12/31/2020
	Operating expenses		Net operating income		Non-operating income (loss)		Provision (benefit) for income taxes(4)		Net income attributable to T. Rowe Price Group		Diluted earnings per share(5)
U.S. GAAP Basis	$	977.0	$	755.9	$	390.1	$	216.4	$	783.4	$	3.33
Non-GAAP adjustments:
Consolidated T. Rowe Price    investment products(1)	(2.1)		4.7		(238.4)		(18.1)		(69.4)		(.30)
Supplemental savings plan liability(2)	(66.4)		66.4		(61.9)		.9		3.6		.02
Other non-operating income(3)	—		—		(47.3)		(9.9)		(37.4)		(.16)
Adjusted Non-GAAP Basis	$	908.5	$	827.0	$	42.5	$	189.3	$	680.2	$	2.89

(1)These non-GAAP adjustments remove the impact that the consolidated T. Rowe Price investment products have on the firm's U.S. GAAP consolidated statements of income. Specifically, the firm adds back the operating expenses and subtracts

14

the investment income of the consolidated T. Rowe Price investment products. The adjustment to operating expenses represents the operating expenses of the consolidated products, net of the elimination of related management and administrative fees. The adjustment to net income attributable to T. Rowe Price Group represents the net income of the consolidated products, net of redeemable non-controlling interests. Management believes the consolidated T. Rowe Price investment products may impact the reader’s ability to understand the firm's core operating results.

(2)This non-GAAP adjustment removes the compensation expense impact from market valuation changes in the supplemental savings plan liability and the related net gains (losses) on investments designated as an economic hedge against the related liability. Amounts deferred under the supplemental savings plan are adjusted for appreciation (depreciation) of hypothetical investments chosen by participants. The firm uses T. Rowe Price investment products to economically hedge the exposure to these market movements. Management believes it is useful to offset the non-operating investment income (loss) realized on the economic hedges against the related compensation expense and remove the net impact to help the reader's ability to understand the firm's core operating results and to increase comparability period to period.

(3)This non-GAAP adjustment represents the other non-operating income (loss) and the net gains (losses) earned on the firm's non-consolidated investment portfolio that are not designated as economic hedges of the supplemental savings plan liability, and that are not part of the cash and discretionary investment portfolio. Management retains the investment gains recognized on the non-consolidated cash and discretionary investments as these assets and related income (loss) are considered part of the firm's core operations. Management believes adjusting for these non-operating income (loss) items helps the reader’s ability to understand the firm's core operating results and increases comparability to prior years. Additionally, management does not emphasize the impact of the portion of non-operating income (loss) removed when managing and evaluating the firm's performance.

(4)The income tax impacts were calculated in order to achieve an overall year-to-date non-GAAP effective tax rate of 23.7% for 2021, 22.5% for Q1 2020, and 21.8% for Q4 2020. The firm estimates that its effective tax rate for the full-year 2021 on a non-GAAP basis will be in the range of 23% to 25%.

(5)This non-GAAP measure was calculated by applying the two-class method to adjusted net income attributable to T. Rowe Price Group divided by the weighted-average common shares outstanding assuming dilution. The calculation of adjusted net income allocated to common stockholders is as follows:

	Three months ended
	3/31/2021		3/31/2020		12/31/2020
Adjusted net income attributable to T. Rowe Price Group	$	712.0	$	454.3	$	680.2
Less: adjusted net income allocated to outstanding restricted stock and stock unit holders	18.9		12.4		18.4
Adjusted net income allocated to common stockholders	$	693.1	$	441.9	$	661.8

15

XML

Cover - shares	3 Months Ended
	Mar. 31, 2021	Apr. 27, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2021
Document Transition Report	false
Entity File Number	000-32191
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	52-2264646
Entity Address, Address Line One	100 East Pratt Street
Entity Address, City or Town	Baltimore
Entity Address, State or Province	MD
Entity Address, Postal Zip Code	21202
City Area Code	410
Local Phone Number	345-2000
Title of 12(b) Security	Common stock, $.20 par value per share
Trading Symbol	TROW
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		226,855,575
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2021
Entity Registrant Name	PRICE T ROWE GROUP INC
Entity Central Index Key	0001113169
Amendment Flag	false

XML

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
ASSETS
Cash and cash equivalents	$ 2,830.1	$ 2,151.7
Accounts receivable and accrued revenue	885.9	863.1
Investments	3,403.6	3,250.8
Assets of consolidated T. Rowe Price investment products ($1,782.9 million at March 31, 2021 and $2,497.4 million at December 31, 2020, related to variable interest entities)	1,946.8	2,695.5
Operating lease assets	110.2	117.6
Property and equipment, net	703.9	695.4
Goodwill	665.7	665.7
Other assets	218.2	219.2
Total assets	10,764.4	10,659.0
LIABILITIES
Accounts payable and accrued expenses	228.9	187.7
Liabilities of consolidated T. Rowe Price investment products ($49.0 million at March 31, 2021 and $47.7 million at December 31, 2020, related to variable interest entities)	53.7	57.7
Operating lease liabilities	146.0	154.1
Accrued compensation and related costs	260.8	133.6
Supplemental savings plan liability	769.9	772.2
Income taxes payable	284.0	85.0
Total liabilities	1,743.3	1,390.3
Commitments and contingent liabilities
Redeemable non-controlling interests	1,012.9	1,561.7
STOCKHOLDERS’ EQUITY
Preferred stock, undesignated, $.20 par value – authorized and unissued 20,000,000 shares	0.0	0.0
Common stock, $.20 par value—authorized 750,000,000; issued 226,948,000 shares at March 31, 2021 and 227,965,000 at December 31, 2020	45.4	45.6
Additional capital in excess of par value	654.6	654.6
Retained earnings	7,338.7	7,029.8
Accumulated other comprehensive loss	(30.5)	(23.0)
Total permanent stockholders’ equity	8,008.2	7,707.0
Total liabilities, redeemable non-controlling interests, and permanent stockholders’ equity	$ 10,764.4	$ 10,659.0

XML

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Assets of consolidated T. Rowe Price investment products	$ 1,946.8	$ 2,695.5
Liabilities of consolidated T. Rowe Price investment products	$ 53.7	$ 57.7
Stockholders' equity
Preferred stock, par value (in dollars per share)	$ 0.20	$ 0.20
Preferred stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, par value (in dollars per share)	$ 0.20	$ 0.20
Common stock, shares authorized (in shares)	750,000,000	750,000,000
Common stock, shares issued (in shares)	226,948,000	227,965,000
Variable interest entities
Assets of consolidated T. Rowe Price investment products	$ 1,782.9	$ 2,497.4
Liabilities of consolidated T. Rowe Price investment products	$ 49.0	$ 47.7

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Revenues
Net revenues	$ 1,826.8	$ 1,462.6
Operating expenses
Compensation and related costs	583.5	440.7
Distribution and servicing	85.6	65.7
Advertising and promotion	18.9	24.9
Product-related costs	41.0	41.6
Technology, occupancy, and facility costs	117.3	105.4
General, administrative, and other	87.3	77.1
Total operating expenses	933.6	755.4
Net operating income	893.2	707.2
Non-operating income (loss)
Net gains (losses) on investments	68.6	(154.6)
Net gains (losses) on consolidated investment products	37.2	(330.3)
Other income (loss)	(3.7)	(15.4)
Total non-operating income (loss)	102.1	(500.3)
Income before income taxes	995.3	206.9
Provision for income taxes	230.5	40.3
Net income	764.8	166.6
Less: net income (loss) attributable to redeemable non-controlling interests	15.4	(176.5)
Net income attributable to T. Rowe Price Group	$ 749.4	$ 343.1
Earnings per share on common stock of T. Rowe Price Group
Basic (in dollars per share)	$ 3.20	$ 1.43
Diluted (in dollars per share)	$ 3.17	$ 1.41
Investment advisory fees
Revenues
Net revenues	$ 1,687.8	$ 1,327.8
Administrative, distribution, and servicing fees
Revenues
Net revenues	$ 139.0	$ 134.8

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Net income	$ 764.8	$ 166.6
Other comprehensive income (loss)
Other comprehensive loss before income taxes	(22.3)	(25.3)
Net deferred tax benefits	3.0	2.0
Total other comprehensive loss	(19.3)	(23.3)
Total comprehensive income	745.5	143.3
Less: comprehensive income (loss) attributable to redeemable non-controlling interests	3.6	(193.7)
Total comprehensive income attributable to T. Rowe Price Group	741.9	337.0
Variable interest entities
Other comprehensive income (loss)
Consolidated T. Rowe Price investment products - variable interest entities	(18.9)	(25.1)
Reclassification gains recognized in non-operating income upon deconsolidation of certain T. Rowe Price investment products	(2.6)	(0.1)
Currency translation adjustments	(21.5)	(25.2)
Equity method investments
Other comprehensive income (loss)
Currency translation adjustments	$ (0.8)	$ (0.1)

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities
Net income	$ 764.8	$ 166.6
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization of property and equipment	49.0	46.1
Stock-based compensation expense	57.5	58.3
Net (gains) losses recognized on investments	(59.5)	167.3
Net change in T. Rowe Price investment products used to economically hedge supplemental savings plan liability	22.0	(8.9)
Net change in securities held by consolidated T. Rowe Price investment products	(120.9)	234.6
Other changes in assets and liabilities	281.8	123.7
Net cash provided by operating activities	994.7	787.7
Cash flows from investing activities
Purchases of T. Rowe Price investment products	(12.5)	(225.1)
Dispositions of T. Rowe Price investment products	60.3	299.1
Net cash of T. Rowe Price investment products on deconsolidation	(27.3)	(0.8)
Additions to property and equipment	(58.8)	(46.0)
Other investing activity	7.5	0.4
Net cash (used in) provided by investing activities	(30.8)	27.6
Cash flows from financing activities
Repurchases of common stock	(259.2)	(891.3)
Common share issuances under stock-based compensation plans	20.9	38.1
Dividends paid to common stockholders of T. Rowe Price Group	(252.3)	(215.2)
Net subscriptions received from redeemable non-controlling interest holders	183.1	76.1
Net cash used in financing activities	(307.5)	(992.3)
Effect of exchange rate changes on cash and cash equivalents of consolidated T. Rowe Price investment products	0.9	(1.2)
Net change in cash and cash equivalents during period	657.3	(178.2)
Cash and cash equivalents at beginning of period	2,256.5	1,858.3
Cash and cash equivalents at ending of period	$ 2,913.8	$ 1,680.1

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020	Mar. 31, 2020	Dec. 31, 2019
Cash and cash equivalents	$ 2,913.8	$ 2,256.5	$ 1,680.1	$ 1,858.3
Consolidated T. Rowe Price investment products
Cash and cash equivalents	$ 83.7	$ 104.8	$ 117.7	$ 76.5

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Total	Restricted stock units	Common stock	Common stock Restricted stock units	Additional capital in excess of par value	Additional capital in excess of par value Restricted stock units	Retained earnings	AOCI	[1]
Beginning balance (in shares) at Dec. 31, 2019			235,214,000
Balances at beginning of period at Dec. 31, 2019	$ 7,102.1		$ 47.0		$ 654.6		$ 6,443.5	$ (43.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	343.1						343.1
Other comprehensive income (loss), net of tax	(6.1)							(6.1)
Dividends declared	(214.7)						(214.7)
Shares issued upon option exercises (in shares)			1,068,000
Shares issued upon option exercises	41.3		$ 0.2		41.1
Net shares issued upon vesting of restricted stock units (in shares)				37,000
Net shares issued upon vesting of restricted stock units		$ (3.0)				$ (3.0)
Stock-based compensation expense	58.3				58.3
Restricted stock units issued as dividend equivalents	0.0				0.1		(0.1)
Common shares repurchased (in shares)			(8,334,000)
Common shares repurchased	(887.0)		$ (1.6)		(96.5)		(788.9)
Ending balance (in shares) at Mar. 31, 2020			227,985,000
Balances at end of period at Mar. 31, 2020	6,434.0		$ 45.6		654.6		5,782.9	(49.1)
Beginning balances attributable to redeemable non-controlling interests at Dec. 31, 2019	1,121.0
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income (loss) attributable to redeemable non-controlling interests	(176.5)
Other comprehensive income (loss), net of tax, attributable to redeemable non-controlling interests	17.2
Net subscriptions into consolidated T. Rowe Price investment products	63.8
Net deconsolidations of T. Rowe Price investment products	(20.1)
Ending balances attributable to redeemable non-controlling interests at Mar. 31, 2020	971.0
Beginning balance (in shares) at Dec. 31, 2020			227,965,000
Balances at beginning of period at Dec. 31, 2020	7,707.0		$ 45.6		654.6		7,029.8	(23.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	749.4						749.4
Other comprehensive income (loss), net of tax	(7.5)							(7.5)
Dividends declared	$ (252.3)						(252.3)
Shares issued upon option exercises (in shares)	748,203		572,000
Shares issued upon option exercises	$ 25.4		$ 0.1		25.3
Net shares issued upon vesting of restricted stock units (in shares)				41,000
Net shares issued upon vesting of restricted stock units		$ (3.7)				$ (3.7)
Stock-based compensation expense	57.5				57.5
Restricted stock units issued as dividend equivalents					0.1		(0.1)
Common shares repurchased (in shares)			(1,630,000)
Common shares repurchased	(267.6)		$ (0.3)		(79.2)		(188.1)
Ending balance (in shares) at Mar. 31, 2021			226,948,000
Balances at end of period at Mar. 31, 2021	8,008.2		$ 45.4		$ 654.6		$ 7,338.7	$ (30.5)
Beginning balances attributable to redeemable non-controlling interests at Dec. 31, 2020	1,561.7
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income (loss) attributable to redeemable non-controlling interests	15.4
Other comprehensive income (loss), net of tax, attributable to redeemable non-controlling interests	11.8
Net subscriptions into consolidated T. Rowe Price investment products	187.5
Net deconsolidations of T. Rowe Price investment products	(739.9)
Ending balances attributable to redeemable non-controlling interests at Mar. 31, 2021	$ 1,012.9

[1] Accumulated other comprehensive income.

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - $ / shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Statement of Stockholders' Equity [Abstract]
Cash dividends declared per share (in dollars per share)	$ 1.08	$ 0.90

XML

THE COMPANY AND BASIS OF PREPARATION.

3 Months Ended

Mar. 31, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

THE COMPANY AND BASIS OF PREPARATION

THE COMPANY AND BASIS OF PREPARATION.

T. Rowe Price Group Inc. derives its consolidated revenues and net income primarily from investment advisory services that its subsidiaries provide to individual and institutional investors in the T. Rowe Price U.S. mutual funds (“U.S. mutual funds”), subadvised funds, separately managed accounts, collective investment trusts, and other

T. Rowe Price products. The other T. Rowe Price products include open-ended investment products offered to investors outside the U.S., and products offered through variable annuity life insurance plans in the U.S. We also provide certain investment advisory clients with related administrative services, including distribution, mutual fund transfer agent, accounting, and shareholder services; participant recordkeeping and transfer agent services for defined contribution retirement plans; brokerage; trust services; and non-discretionary advisory services through model delivery.

Investment advisory revenues depend largely on the total value and composition of assets under our management. Accordingly, fluctuations in financial markets and in the composition of assets under management impact our revenues and results of operations.

BASIS OF PRESENTATION.

These unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States. These principles require the use of estimates and reflect all adjustments that are, in the opinion of management, necessary for a fair statement of our results for the interim periods presented. All such adjustments are of a normal recurring nature. Actual results may vary from our estimates. Certain prior year amounts have been reclassified to conform to the 2021 presentation.

The unaudited interim financial information contained in these unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements contained in our 2020 Annual Report.

NEWLY ISSUED BUT NOT YET ADOPTED ACCOUNTING GUIDANCE

We have considered all newly issued accounting guidance that is applicable to our operations and the preparation of our unaudited condensed consolidated statements, including those we have not yet adopted. We do not believe that any such guidance has or will have a material effect on our financial position or results of operations.

XML

INFORMATION ABOUT RECEIVABLES, REVENUES, AND SERVICES.

3 Months Ended

Mar. 31, 2021

Information about Receivables, Revenues, and Services [Abstract]

INFORMATION ABOUT RECEIVABLES, REVENUES, AND SERVICES

INFORMATION ABOUT RECEIVABLES, REVENUES, AND SERVICES.

Revenues earned under agreements with clients include: 

	Three months ended 3/31/2021								Three months ended 3/31/2020
			Administrative, distribution, and servicing fees								Administrative, distribution, and servicing fees
(in millions)	Investment advisory fees		Administrative fees		Distribution and servicing fees		Net revenues		Investment advisory fees		Administrative fees		Distribution and servicing fees		Net revenues
U.S. mutual funds	$	1,050.2	$	78.7	$	29.1	$	1,158.0	$	876.2	$	77.2	$	27.9	$	981.3
Subadvised funds, separate accounts, collective investment trusts, and other investment products	637.6		—		—		637.6		451.6		—		—		451.6
Other clients(1)	—		31.2		—		31.2		—		29.7		—		29.7
	$	1,687.8	$	109.9	$	29.1	$	1,826.8	$	1,327.8	$	106.9	$	27.9	$	1,462.6

(1) Other clients primarily include individuals, defined contribution plans, college savings plans, and institutions related to model delivery.    

Total net revenues earned from our related parties, specifically T. Rowe Price investment products, aggregate $1,482.3 million and $1,207.7 million for the three months ended March 31, 2021 and 2020, respectively. Accounts

receivable from these products aggregate to $540.0 million at March 31, 2021, and $523.4 million at December 31, 2020.

In the second quarter of 2020, we changed our fee structure of the target date retirement funds such that our investment advisory fee revenue is now earned at the target date retirement fund level rather than at the underlying mutual fund level. As a result, we have modified our investment advisory fee and assets under management presentation below to separately breakout the fees earned and assets under management of our multi-asset portfolios. All prior periods have been recast to conform to this new presentation and to provide comparability.

The following table details the investment advisory fees earned from clients by their underlying asset class.

	Three months ended
(in millions)	3/31/2021		3/31/2020
U.S. mutual funds
Equity	$	729.8	$	568.4
Fixed income, including money market	59.0		71.7
Multi-asset	261.4		236.1
	1,050.2		876.2
Subadvised funds, separate accounts, collective investment trusts, and other investment products
Equity	429.8		279.5
Fixed income, including money market	31.7		38.0
Multi-asset	176.1		134.1
	637.6		451.6
Total	$	1,687.8	$	1,327.8

The following table summarizes the assets under management on which we earn investment advisory fees.

	Average during
	Three months ended				As of
(in billions)	3/31/2021		3/31/2020		3/31/2021		12/31/2020
U.S. mutual funds
Equity	$	509.6	$	388.3	$	511.7	$	498.6
Fixed income, including money market	82.3		75.7		82.6		79.4
Multi-asset	222.6		190.3		222.1		216.6
	814.5		654.3		816.4		794.6
Subadvised funds, separate accounts, collective investment trusts, and other investment products
Equity	418.9		277.5		405.5		397.2
Fixed income, including money market	80.2		81.3		90.2		89.3
Multi-asset	195.2		149.6		205.9		189.4
	694.3		508.4		701.6		675.9
Total	$	1,508.8	$	1,162.7	$	1,518.0	$	1,470.5

Investors that we serve are primarily domiciled in the U.S.; investment advisory clients outside the U.S. account for 8.8% and 9.3% of our assets under management at March 31, 2021, and December 31, 2020, respectively.

XML

INVESTMENTS.

3 Months Ended

Mar. 31, 2021

Investments, Debt and Equity Securities [Abstract]

INVESTMENTS

INVESTMENTS.

The carrying values of our investments that are not part of the consolidated T. Rowe Price investment products are as follows:

(in millions)	3/31/2021		12/31/2020
Investments held at fair value
T. Rowe Price investment products
Discretionary investments	$	1,664.3	$	1,647.7
Seed capital	269.5		169.5
Supplemental savings plan liability economic hedges	766.9		768.1
Investment partnerships and other investments	100.6		95.1
Equity method investments
T. Rowe Price investment products
Discretionary investments	245.8		242.9
Seed capital	203.7		178.6
23% investment in UTI Asset Management Company Limited (India)	149.1		145.5
Investment partnerships and other investments	2.7		2.4
U.S. Treasury note	1.0		1.0
Total	$	3,403.6	$	3,250.8

The investment partnerships are carried at fair value using net asset value (“NAV”) per share as a practical expedient. Our interests in these partnerships are generally not redeemable and are subject to significant transferability restrictions. The underlying investments of these partnerships have contractual terms through 2029, though we may receive distributions of liquidating assets over a longer term. The investment strategies of these partnerships include growth equity, buyout, venture capital, and real estate.

During the three months ended March 31, 2021, net gains on investments included $38.8 million of net unrealized gains related to investments held at fair value that were still held at March 31, 2021. For the same period of 2020, net losses on investments included $103.6 million of net unrealized losses related to investments held at fair value that were still held at March 31, 2020.

During the three months ended March 31, 2021 and 2020, certain T. Rowe Price investment products in which we provided initial seed capital at the time of formation were deconsolidated, as we no longer had a controlling interest. Depending on our ownership interest, we are now reporting our residual interests in these T. Rowe Price investment products as either an equity method investment or an investment held at fair value. Additionally, during the three months ended March 31, 2020, certain T. Rowe Price investment products that were being accounted for as equity method investments were consolidated, as we regained a controlling interest. The net impact of these changes on our unaudited condensed consolidated balance sheets and statements of income as of the dates the portfolios were deconsolidated or reconsolidated is detailed below.

	Three months ended
(in millions)	3/31/2021		3/31/2020
Net decrease in assets of consolidated T. Rowe Price investment products	$	(928.1)	$	(46.2)
Net decrease in liabilities of consolidated T. Rowe Price investment products	$	(15.3)	$	(2.4)
Net decrease in redeemable non-controlling interests	$	(739.9)	$	(20.1)
Gains recognized upon deconsolidation	$	2.6	$	.1

The gains or losses recognized upon deconsolidation were the result of reclassifying currency translation adjustments accumulated on certain T. Rowe Price investment products with non-USD functional currencies from accumulated other comprehensive income to non-operating income.

VARIABLE INTEREST ENTITIES.

Our investments at March 31, 2021 and December 31, 2020, include interests in variable interest entities that we do not consolidate as we are not deemed the primary beneficiary. Our maximum risk of loss related to our involvement with these entities is as follows:

(in millions)	3/31/2021		12/31/2020
Investment carrying values	$	289.6	$	144.7
Unfunded capital commitments	11.3		12.3
Accounts receivable	60.7		13.8
	$	361.6	$	170.8

The unfunded capital commitments totaling $11.3 million at March 31, 2021 and $12.3 million at December 31, 2020 relate primarily to the investment partnerships in which we have an existing investment. In addition to such amounts, a percentage of prior distributions may be called under certain circumstances.

XML

FAIR VALUE MEASUREMENTS.

3 Months Ended

Mar. 31, 2021

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS.

We determine the fair value of our cash equivalents and investments held at fair value using the following broad levels of inputs as defined by related accounting standards:

Level 1 – quoted prices in active markets for identical securities.

Level 2 – observable inputs other than Level 1 quoted prices including, but not limited to, quoted prices for similar

     securities, interest rates, prepayment speeds, and credit risk. These inputs are based on market data

     obtained from independent sources.

Level 3 – unobservable inputs reflecting our own assumptions based on the best information available. We do not

        value any investments using Level 3 inputs.

These levels are not necessarily an indication of the risk or liquidity associated with our investments. The following table summarizes our investments that are recognized in our unaudited condensed consolidated balance sheets using fair value measurements determined based on the differing levels of inputs. This table excludes investments held by the consolidated T. Rowe Price investment products which are presented separately on our unaudited condensed consolidated balance sheets and are detailed in Note 5.

	3/31/2021				12/31/2020
(in millions)	Level 1		Level 2		Level 1		Level 2
T. Rowe Price investment products
Cash equivalents held in money market funds	2,487.5		$	—	$	1,931.1	$	—
Discretionary investments	1,664.3		—		1,647.7		—
Seed capital	254.6		14.9		156.6		12.9
Supplemental savings plan liability economic hedges	766.9				768.1		—
Other investments	.2		.7		.5		.6
Total	$	5,173.5	$	15.6	$	4,504.0	$	13.5

The fair value hierarchy level table above does not include the investment partnerships and other investments for which fair value is estimated using their NAV per share as a practical expedient. The carrying value of these investments as disclosed in Note 3 were $99.7 million at March 31, 2021, and $94.0 million at December 31, 2020.

XML

CONSOLIDATED T. ROWE PRICE INVESTMENT PRODUCTS.

3 Months Ended

Mar. 31, 2021

Consolidated Sponsored Investment Portfolios [Abstract]

CONSOLIDATED T. ROWE PRICE INVESTMENT PRODUCTS

CONSOLIDATED T. ROWE PRICE INVESTMENT PRODUCTS.The T. Rowe Price investment products that we consolidate in our unaudited condensed consolidated financial statements are generally those products we provided initial seed capital at the time of their formation and have a controlling interest. Our U.S. mutual funds are considered voting interest entities, while those regulated outside the U.S. are considered variable interest entities.

The following table details the net assets of the consolidated T. Rowe Price investment products:

	3/31/2021						12/31/2020
(in millions)	Voting interest entities		Variable interest entities		Total		Voting interest entities		Variable interest entities		Total
Cash and cash equivalents(1)	$	3.0	$	80.7	$	83.7	$	7.1	$	97.7	$	104.8
Investments(2)	157.5		1,664.5		1,822.0		188.2		2,372.7		2,560.9
Other assets	3.4		37.7		41.1		2.8		27.0		29.8
Total assets	163.9		1,782.9		1,946.8		198.1		2,497.4		2,695.5
Liabilities	4.7		49.0		53.7		10.0		47.7		57.7
Net assets	$	159.2	$	1,733.9	$	1,893.1	$	188.1	$	2,449.7	$	2,637.8
Attributable to T. Rowe Price Group	$	96.4	$	783.8	$	880.2	$	130.7	$	945.4	$	1,076.1
Attributable to redeemable non-controlling interests	62.8		950.1		1,012.9		57.4		1,504.3		1,561.7
	$	159.2	$	1,733.9	$	1,893.1	$	188.1	$	2,449.7	$	2,637.8

(1) Cash and cash equivalents includes $2.8 million at March 31, 2021, and $7.0 million at December 31, 2020, of T. Rowe Price money market mutual funds.

(2) Investments include $24.4 million at March 31, 2021, and $26.9 million at December 31, 2020 of other T. Rowe Price investment products.

Although we can redeem our net interest in these consolidated T. Rowe Price investment products at any time, we cannot directly access or sell the assets held by these products to obtain cash for general operations. Additionally, the assets of these investment products are not available to our general creditors.

Since third party investors in these investment products have no recourse to our credit, our overall risk related to the net assets of consolidated T. Rowe Price investment products is limited to valuation changes associated with our net interest. We, however, are required to recognize the valuation changes associated with all underlying investments held by these products in our unaudited condensed consolidated statements of income and disclose the portion attributable to third party investors as net income attributable to redeemable non-controlling interests.

The operating results of the consolidated T. Rowe Price investment products for the three months ended March 31, 2021 and 2020, are reflected in our unaudited condensed consolidated statements of income as follows:

	Three months ended
	3/31/2021						3/31/2020
(in millions)	Voting interest entities		Variable interest entities		Total		Voting interest entities		Variable interest entities		Total
Operating expenses reflected in net operating income	$	(.2)	$	(3.3)	$	(3.5)	$	(.2)	$	(3.5)	$	(3.7)
Net investment income (loss) reflected in non-operating income (loss)	6.1		31.1		37.2		(35.2)		(295.1)		(330.3)
Impact on income before taxes	$	5.9	$	27.8	$	33.7	$	(35.4)	$	(298.6)	$	(334.0)
Net income (loss) attributable to T. Rowe Price Group	$	4.0	$	14.3	$	18.3	$	(22.6)	$	(134.9)	$	(157.5)
Net income (loss) attributable to redeemable non-controlling interests	1.9		13.5		15.4		(12.8)		(163.7)		(176.5)
	$	5.9	$	27.8	$	33.7	$	(35.4)	$	(298.6)	$	(334.0)

The operating expenses of the consolidated investment products are reflected in other operating expenses. In preparing our unaudited condensed consolidated financial statements, we eliminated operating expenses of $1.3 million and $2.5 million for the three months ended March 31, 2021 and 2020, respectively, against the investment advisory and administrative fees earned from these products. The net investment income (loss) reflected in non-

operating income (loss) includes dividend and interest income and realized and unrealized gains and losses on the underlying securities held by the consolidated T. Rowe Price investment products.

The table below details the impact of these consolidated investment products on the individual lines of our unaudited condensed consolidated statements of cash flows for the three months ended March 31, 2021 and 2020.

	Three months ended
	3/31/2021						3/31/2020
(in millions)	Voting interest entities		Variable interest entities		Total		Voting interest entities		Variable interest entities		Total
Net cash provided by (used in) operating activities	$	(31.7)	$	(112.0)	$	(143.7)	$	11.3	$	(87.0)	$	(75.7)
Net cash used in investing activities	(9.1)		(18.2)		(27.3)		(.8)		—		(.8)
Net cash provided by financing activities	36.7		112.3		149.0		2.7		116.2		118.9
Effect of exchange rate changes on cash and cash equivalents of consolidated T. Rowe Price investment products	—		.9		.9		—		(1.2)		(1.2)
Net change in cash and cash equivalents during period	(4.1)		(17.0)		(21.1)		13.2		28.0		41.2
Cash and cash equivalents at beginning of year	7.1		97.7		104.8		9.9		66.6		76.5
Cash and cash equivalents at end of period	$	3.0	$	80.7	$	83.7	$	23.1	$	94.6	$	117.7

The net cash provided by financing activities during the three months ended March 31, 2021 and 2020 includes $34.1 million and $42.8 million, respectively, of net subscriptions we made into the consolidated T. Rowe Price investment products, net of dividends received. These cash flows were eliminated in consolidation.

FAIR VALUE MEASUREMENTS.

We determine the fair value of investments held by consolidated T. Rowe Price investment products using the following broad levels of inputs as defined by related accounting standards:

Level 1 – quoted prices in active markets for identical securities.

Level 2 – observable inputs other than Level 1 quoted prices including, but not limited to, quoted prices for similar securities, interest rates, prepayment speeds, and credit risk. These inputs are based on market data obtained from independent sources.

Level 3 – unobservable inputs reflecting our own assumptions based on the best information available. The value of investments using Level 3 inputs is insignificant.

These levels are not necessarily an indication of the risk or liquidity associated with these investment holdings. The following table summarizes the investment holdings held by our consolidated T. Rowe Price investment products using fair value measurements determined based on the differing levels of inputs.

	3/31/2021				12/31/2020
(in millions)	Level 1		Level 2		Level 1		Level 2
Assets
Cash equivalents	$	2.8	$	—	$	7.0	$	—
Equity securities	225.7		449.9		308.0		708.0
Fixed income securities	—		1,107.2		—		1,411.3
Other investments	4.0		35.2		2.6		131.0
	$	232.5	$	1,592.3	$	317.6	$	2,250.3
Liabilities	$	(.4)	$	(9.9)	$	(.4)	$	(18.8)

XML

STOCKHOLDERS' EQUITY.	3 Months Ended
	Mar. 31, 2021
Stockholders' Equity Note [Abstract]
STOCKHOLDERS’ EQUITY	STOCKHOLDERS’ EQUITY.Accounts payable and accrued expenses includes liabilities of $10.9 million at March 31, 2021, and $2.5 million at December 31, 2020, for common stock repurchases that settled during the first week of April 2021 and January 2021, respectively.

XML

STOCK-BASED COMPENSATION.

3 Months Ended

Mar. 31, 2021

Share-based Payment Arrangement [Abstract]

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION.

STOCK OPTIONS.

The following table summarizes the status of, and changes in, our stock options during the three months ended March 31, 2021.

	Options	Weighted- average exercise price
Outstanding at December 31, 2020	4,329,056	$	72.52
Exercised	(748,203)	$	72.28
Outstanding at March 31, 2021	3,580,853	$	72.57
Exercisable at March 31, 2021	3,580,853	$	72.57

RESTRICTED SHARES AND STOCK UNITS.

The following table summarizes the status of, and changes in, our nonvested restricted shares and restricted stock units during the three months ended March 31, 2021.

	Restricted shares	Restricted stock units	Weighted-average fair value
Nonvested at December 31, 2020	7,412	6,367,059	$	116.51
Time-based grants	—	3,397	$	154.03
Dividend equivalents granted to non-employee directors	—	550	$	172.22
Vested	—	(64,942)	$	97.37
Forfeited	—	(19,489)	$	114.66
Nonvested at March 31, 2021	7,412	6,286,575	$	116.73

Nonvested at March 31, 2021, includes performance-based restricted stock units of 361,609. These nonvested performance-based restricted stock units include 198,205 units for which the performance period has lapsed, and the performance threshold has been met.

FUTURE STOCK-BASED COMPENSATION EXPENSE.

The following table presents the compensation expense to be recognized over the remaining vesting periods of the stock-based awards outstanding at March 31, 2021. Estimated future compensation expense will change to reflect future grants of restricted stock awards and units, future option grants, changes in the probability of performance thresholds being met, and adjustments for actual forfeitures.

(in millions)
Second quarter 2021	$	56.9
Third quarter 2021	56.7
Fourth quarter 2021	50.2
2022	117.4
2023 through 2026	97.2
Total	$	378.4

XML

EARNINGS PER SHARE CALCULATIONS.

3 Months Ended

Mar. 31, 2021

Earnings Per Share [Abstract]

EARNINGS PER SHARE CALCULATIONS

EARNINGS PER SHARE CALCULATIONS.

The following table presents the reconciliation of net income attributable to T. Rowe Price Group to net income allocated to our common stockholders and the weighted-average shares that are used in calculating the basic and diluted earnings per share on our common stock. Weighted-average common shares outstanding assuming dilution reflects the potential dilution, determined using the treasury stock method, that could occur if outstanding stock options were exercised and non-participating stock awards vested. No outstanding stock options had an anti-dilutive impact on the diluted earnings per common share calculation in the periods presented.

	Three months ended
(in millions)	3/31/2021		3/31/2020
Net income attributable to T. Rowe Price Group	749.4		$	343.1
Less: net income allocated to outstanding restricted stock and stock unit holders	19.9		9.4
Net income allocated to common stockholders	$	729.5	$	333.7
Weighted-average common shares
Outstanding	227.7		234.1
Outstanding assuming dilution	230.0		236.8

XML

OTHER COMPREHENSIVE INCOME AND ACCUMULATED OTHER COMPREHENSIVE LOSS.

3 Months Ended

Mar. 31, 2021

Stockholders' Equity Note [Abstract]

OTHER COMPREHENSIVE INCOME AND ACCUMULATED OTHER COMPREHENSIVE LOSS

OTHER COMPREHENSIVE INCOME AND ACCUMULATED OTHER COMPREHENSIVE LOSS.

The changes in each component of accumulated other comprehensive loss, including reclassification adjustments for the three months ended March 31, 2021 and 2020 are presented in the table below.

	Three months ended 3/31/2021						Three months ended 3/31/2020
(in millions)	Equity method investments		Consolidated T. Rowe Price investment products - variable interest entities		Total currency translation adjustments		Equity method investments		Consolidated T. Rowe Price investment products - variable interest entities		Total currency translation adjustments
Balances at beginning of period	$	(43.6)	$	20.6	$	(23.0)	$	(46.9)	$	3.9	$	(43.0)
Other comprehensive income (loss) before reclassifications and income taxes	(.8)		(7.1)		(7.9)		(.1)		(7.9)		(8.0)
Reclassification adjustments recognized in non-operating income	—		(2.6)		(2.6)		—		(.1)		(.1)
	(.8)		(9.7)		(10.5)		(.1)		(8.0)		(8.1)
Net deferred tax benefits (income taxes)	.5		2.5		3.0		—		2.0		2.0
Other comprehensive income (loss)	(.3)		(7.2)		(7.5)		(.1)		(6.0)		(6.1)
Balances at end of period	$	(43.9)	$	13.4	$	(30.5)	$	(47.0)	$	(2.1)	$	(49.1)

The other comprehensive income (loss) in the table above excludes $11.8 million and $17.2 million of other comprehensive loss related to redeemable non-controlling interests held in our consolidated products for the three months ended March 31, 2021 and 2020, respectively.

XML

COMMITMENTS AND CONTINGENCIES.

3 Months Ended

Mar. 31, 2021

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES.

On February 14, 2017, T. Rowe Price Group, Inc., T. Rowe Price Associates, Inc., T. Rowe Price Trust Company, current and former members of the management committee, and trustees of the T. Rowe Price U.S. Retirement Program were named as defendants in a lawsuit filed in the United States District Court for the District of Maryland. The lawsuit alleges breaches of ERISA’s fiduciary duty and prohibited transaction provisions on behalf of a class of all participants and beneficiaries of the T. Rowe Price 401(k) Plan from February 14, 2011, to the time of judgment. The matter has been certified as a class action. T. Rowe Price believes the claims are without merit and is vigorously defending the action. The parties each filed motions for summary judgment and, with the exception of one claim, the court has denied the parties’ cross motions for summary judgment. A trial has been scheduled to begin in September 2021. We cannot predict the eventual outcome, or whether it will have a material negative impact on our financial results, or estimate the possible loss or range of loss that may arise from any negative outcome.

In addition to the matter discussed above, various claims against us arise in the ordinary course of business, including employment-related claims. In the opinion of management, after consultation with counsel, the likelihood of an adverse determination in one or more of these pending ordinary course of business claims that would have a material adverse effect on our financial position or results of operations is remote.

XML

THE COMPANY AND BASIS OF PREPARATION. (Policies)

3 Months Ended

Mar. 31, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

New Accounting Guidance and Newly Issued But Not Yet Adopted Accounting Guidance

NEWLY ISSUED BUT NOT YET ADOPTED ACCOUNTING GUIDANCE

We have considered all newly issued accounting guidance that is applicable to our operations and the preparation of our unaudited condensed consolidated statements, including those we have not yet adopted. We do not believe that any such guidance has or will have a material effect on our financial position or results of operations.

XML

INFORMATION ABOUT RECEIVABLES, REVENUES, AND SERVICES. (Tables)

3 Months Ended

Mar. 31, 2021

Information about Receivables, Revenues, and Services [Abstract]

Components of revenues from advisory services

Revenues earned under agreements with clients include: 

	Three months ended 3/31/2021								Three months ended 3/31/2020
			Administrative, distribution, and servicing fees								Administrative, distribution, and servicing fees
(in millions)	Investment advisory fees		Administrative fees		Distribution and servicing fees		Net revenues		Investment advisory fees		Administrative fees		Distribution and servicing fees		Net revenues
U.S. mutual funds	$	1,050.2	$	78.7	$	29.1	$	1,158.0	$	876.2	$	77.2	$	27.9	$	981.3
Subadvised funds, separate accounts, collective investment trusts, and other investment products	637.6		—		—		637.6		451.6		—		—		451.6
Other clients(1)	—		31.2		—		31.2		—		29.7		—		29.7
	$	1,687.8	$	109.9	$	29.1	$	1,826.8	$	1,327.8	$	106.9	$	27.9	$	1,462.6

(1) Other clients primarily include individuals, defined contribution plans, college savings plans, and institutions related to model delivery.    

The following table details the investment advisory fees earned from clients by their underlying asset class.

	Three months ended
(in millions)	3/31/2021		3/31/2020
U.S. mutual funds
Equity	$	729.8	$	568.4
Fixed income, including money market	59.0		71.7
Multi-asset	261.4		236.1
	1,050.2		876.2
Subadvised funds, separate accounts, collective investment trusts, and other investment products
Equity	429.8		279.5
Fixed income, including money market	31.7		38.0
Multi-asset	176.1		134.1
	637.6		451.6
Total	$	1,687.8	$	1,327.8

Components of assets under management

The following table summarizes the assets under management on which we earn investment advisory fees.

	Average during
	Three months ended				As of
(in billions)	3/31/2021		3/31/2020		3/31/2021		12/31/2020
U.S. mutual funds
Equity	$	509.6	$	388.3	$	511.7	$	498.6
Fixed income, including money market	82.3		75.7		82.6		79.4
Multi-asset	222.6		190.3		222.1		216.6
	814.5		654.3		816.4		794.6
Subadvised funds, separate accounts, collective investment trusts, and other investment products
Equity	418.9		277.5		405.5		397.2
Fixed income, including money market	80.2		81.3		90.2		89.3
Multi-asset	195.2		149.6		205.9		189.4
	694.3		508.4		701.6		675.9
Total	$	1,508.8	$	1,162.7	$	1,518.0	$	1,470.5

XML

INVESTMENTS. (Tables)

3 Months Ended

Mar. 31, 2021

Investments, Debt and Equity Securities [Abstract]

Unconsolidated investments

The carrying values of our investments that are not part of the consolidated T. Rowe Price investment products are as follows:

(in millions)	3/31/2021		12/31/2020
Investments held at fair value
T. Rowe Price investment products
Discretionary investments	$	1,664.3	$	1,647.7
Seed capital	269.5		169.5
Supplemental savings plan liability economic hedges	766.9		768.1
Investment partnerships and other investments	100.6		95.1
Equity method investments
T. Rowe Price investment products
Discretionary investments	245.8		242.9
Seed capital	203.7		178.6
23% investment in UTI Asset Management Company Limited (India)	149.1		145.5
Investment partnerships and other investments	2.7		2.4
U.S. Treasury note	1.0		1.0
Total	$	3,403.6	$	3,250.8

Net impact of deconsolidation and consolidation on condensed consolidated balance sheets and income statements

The net impact of these changes on our unaudited condensed consolidated balance sheets and statements of income as of the dates the portfolios were deconsolidated or reconsolidated is detailed below.

	Three months ended
(in millions)	3/31/2021		3/31/2020
Net decrease in assets of consolidated T. Rowe Price investment products	$	(928.1)	$	(46.2)
Net decrease in liabilities of consolidated T. Rowe Price investment products	$	(15.3)	$	(2.4)
Net decrease in redeemable non-controlling interests	$	(739.9)	$	(20.1)
Gains recognized upon deconsolidation	$	2.6	$	.1

Maximum risk of loss related to investments in variable interest entities

Our investments at March 31, 2021 and December 31, 2020, include interests in variable interest entities that we do not consolidate as we are not deemed the primary beneficiary. Our maximum risk of loss related to our involvement with these entities is as follows:

(in millions)	3/31/2021		12/31/2020
Investment carrying values	$	289.6	$	144.7
Unfunded capital commitments	11.3		12.3
Accounts receivable	60.7		13.8
	$	361.6	$	170.8

XML

FAIR VALUE MEASUREMENTS. (Tables)

3 Months Ended

Mar. 31, 2021

Fair Value Disclosures [Abstract]

Fair value measurements summary

The following table summarizes our investments that are recognized in our unaudited condensed consolidated balance sheets using fair value measurements determined based on the differing levels of inputs. This table excludes investments held by the consolidated T. Rowe Price investment products which are presented separately on our unaudited condensed consolidated balance sheets and are detailed in Note 5.

	3/31/2021				12/31/2020
(in millions)	Level 1		Level 2		Level 1		Level 2
T. Rowe Price investment products
Cash equivalents held in money market funds	2,487.5		$	—	$	1,931.1	$	—
Discretionary investments	1,664.3		—		1,647.7		—
Seed capital	254.6		14.9		156.6		12.9
Supplemental savings plan liability economic hedges	766.9				768.1		—
Other investments	.2		.7		.5		.6
Total	$	5,173.5	$	15.6	$	4,504.0	$	13.5

XML

CONSOLIDATED T. ROWE PRICE INVESTMENT PRODUCTS. (Tables)

3 Months Ended

Mar. 31, 2021

Consolidated Sponsored Investment Portfolios [Abstract]

Net assets of consolidated sponsored investment portfolios

The following table details the net assets of the consolidated T. Rowe Price investment products:

	3/31/2021						12/31/2020
(in millions)	Voting interest entities		Variable interest entities		Total		Voting interest entities		Variable interest entities		Total
Cash and cash equivalents(1)	$	3.0	$	80.7	$	83.7	$	7.1	$	97.7	$	104.8
Investments(2)	157.5		1,664.5		1,822.0		188.2		2,372.7		2,560.9
Other assets	3.4		37.7		41.1		2.8		27.0		29.8
Total assets	163.9		1,782.9		1,946.8		198.1		2,497.4		2,695.5
Liabilities	4.7		49.0		53.7		10.0		47.7		57.7
Net assets	$	159.2	$	1,733.9	$	1,893.1	$	188.1	$	2,449.7	$	2,637.8
Attributable to T. Rowe Price Group	$	96.4	$	783.8	$	880.2	$	130.7	$	945.4	$	1,076.1
Attributable to redeemable non-controlling interests	62.8		950.1		1,012.9		57.4		1,504.3		1,561.7
	$	159.2	$	1,733.9	$	1,893.1	$	188.1	$	2,449.7	$	2,637.8

(1) Cash and cash equivalents includes $2.8 million at March 31, 2021, and $7.0 million at December 31, 2020, of T. Rowe Price money market mutual funds.

(2) Investments include $24.4 million at March 31, 2021, and $26.9 million at December 31, 2020 of other T. Rowe Price investment products.

Operating results of consolidated sponsored investment portfolios

The operating results of the consolidated T. Rowe Price investment products for the three months ended March 31, 2021 and 2020, are reflected in our unaudited condensed consolidated statements of income as follows:

	Three months ended
	3/31/2021						3/31/2020
(in millions)	Voting interest entities		Variable interest entities		Total		Voting interest entities		Variable interest entities		Total
Operating expenses reflected in net operating income	$	(.2)	$	(3.3)	$	(3.5)	$	(.2)	$	(3.5)	$	(3.7)
Net investment income (loss) reflected in non-operating income (loss)	6.1		31.1		37.2		(35.2)		(295.1)		(330.3)
Impact on income before taxes	$	5.9	$	27.8	$	33.7	$	(35.4)	$	(298.6)	$	(334.0)
Net income (loss) attributable to T. Rowe Price Group	$	4.0	$	14.3	$	18.3	$	(22.6)	$	(134.9)	$	(157.5)
Net income (loss) attributable to redeemable non-controlling interests	1.9		13.5		15.4		(12.8)		(163.7)		(176.5)
	$	5.9	$	27.8	$	33.7	$	(35.4)	$	(298.6)	$	(334.0)

Cash flows of consolidated sponsored investment portfolios

The table below details the impact of these consolidated investment products on the individual lines of our unaudited condensed consolidated statements of cash flows for the three months ended March 31, 2021 and 2020.

	Three months ended
	3/31/2021						3/31/2020
(in millions)	Voting interest entities		Variable interest entities		Total		Voting interest entities		Variable interest entities		Total
Net cash provided by (used in) operating activities	$	(31.7)	$	(112.0)	$	(143.7)	$	11.3	$	(87.0)	$	(75.7)
Net cash used in investing activities	(9.1)		(18.2)		(27.3)		(.8)		—		(.8)
Net cash provided by financing activities	36.7		112.3		149.0		2.7		116.2		118.9
Effect of exchange rate changes on cash and cash equivalents of consolidated T. Rowe Price investment products	—		.9		.9		—		(1.2)		(1.2)
Net change in cash and cash equivalents during period	(4.1)		(17.0)		(21.1)		13.2		28.0		41.2
Cash and cash equivalents at beginning of year	7.1		97.7		104.8		9.9		66.6		76.5
Cash and cash equivalents at end of period	$	3.0	$	80.7	$	83.7	$	23.1	$	94.6	$	117.7

Fair values of investments held by consolidated sponsored investment portfolios

The following table summarizes the investment holdings held by our consolidated T. Rowe Price investment products using fair value measurements determined based on the differing levels of inputs.

	3/31/2021				12/31/2020
(in millions)	Level 1		Level 2		Level 1		Level 2
Assets
Cash equivalents	$	2.8	$	—	$	7.0	$	—
Equity securities	225.7		449.9		308.0		708.0
Fixed income securities	—		1,107.2		—		1,411.3
Other investments	4.0		35.2		2.6		131.0
	$	232.5	$	1,592.3	$	317.6	$	2,250.3
Liabilities	$	(.4)	$	(9.9)	$	(.4)	$	(18.8)

XML

STOCK-BASED COMPENSATION. (Tables)

3 Months Ended

Mar. 31, 2021

Share-based Payment Arrangement [Abstract]

Rollforward of stock options

The following table summarizes the status of, and changes in, our stock options during the three months ended March 31, 2021.

	Options	Weighted- average exercise price
Outstanding at December 31, 2020	4,329,056	$	72.52
Exercised	(748,203)	$	72.28
Outstanding at March 31, 2021	3,580,853	$	72.57
Exercisable at March 31, 2021	3,580,853	$	72.57

Rollforward of nonvested restricted shares and restricted stock units

The following table summarizes the status of, and changes in, our nonvested restricted shares and restricted stock units during the three months ended March 31, 2021.

	Restricted shares	Restricted stock units	Weighted-average fair value
Nonvested at December 31, 2020	7,412	6,367,059	$	116.51
Time-based grants	—	3,397	$	154.03
Dividend equivalents granted to non-employee directors	—	550	$	172.22
Vested	—	(64,942)	$	97.37
Forfeited	—	(19,489)	$	114.66
Nonvested at March 31, 2021	7,412	6,286,575	$	116.73

Future stock-based compensation expense

The following table presents the compensation expense to be recognized over the remaining vesting periods of the stock-based awards outstanding at March 31, 2021. Estimated future compensation expense will change to reflect future grants of restricted stock awards and units, future option grants, changes in the probability of performance thresholds being met, and adjustments for actual forfeitures.

(in millions)
Second quarter 2021	$	56.9
Third quarter 2021	56.7
Fourth quarter 2021	50.2
2022	117.4
2023 through 2026	97.2
Total	$	378.4

XML

EARNINGS PER SHARE CALCULATIONS. (Tables)

3 Months Ended

Mar. 31, 2021

Earnings Per Share [Abstract]

Earnings per share reconciliation

The following table presents the reconciliation of net income attributable to T. Rowe Price Group to net income allocated to our common stockholders and the weighted-average shares that are used in calculating the basic and diluted earnings per share on our common stock. Weighted-average common shares outstanding assuming dilution reflects the potential dilution, determined using the treasury stock method, that could occur if outstanding stock options were exercised and non-participating stock awards vested. No outstanding stock options had an anti-dilutive impact on the diluted earnings per common share calculation in the periods presented.

	Three months ended
(in millions)	3/31/2021		3/31/2020
Net income attributable to T. Rowe Price Group	749.4		$	343.1
Less: net income allocated to outstanding restricted stock and stock unit holders	19.9		9.4
Net income allocated to common stockholders	$	729.5	$	333.7
Weighted-average common shares
Outstanding	227.7		234.1
Outstanding assuming dilution	230.0		236.8

XML

OTHER COMPREHENSIVE INCOME AND ACCUMULATED OTHER COMPREHENSIVE LOSS. (Tables)

3 Months Ended

Mar. 31, 2021

Stockholders' Equity Note [Abstract]

Changes in accumulated other comprehensive loss

The changes in each component of accumulated other comprehensive loss, including reclassification adjustments for the three months ended March 31, 2021 and 2020 are presented in the table below.

	Three months ended 3/31/2021						Three months ended 3/31/2020
(in millions)	Equity method investments		Consolidated T. Rowe Price investment products - variable interest entities		Total currency translation adjustments		Equity method investments		Consolidated T. Rowe Price investment products - variable interest entities		Total currency translation adjustments
Balances at beginning of period	$	(43.6)	$	20.6	$	(23.0)	$	(46.9)	$	3.9	$	(43.0)
Other comprehensive income (loss) before reclassifications and income taxes	(.8)		(7.1)		(7.9)		(.1)		(7.9)		(8.0)
Reclassification adjustments recognized in non-operating income	—		(2.6)		(2.6)		—		(.1)		(.1)
	(.8)		(9.7)		(10.5)		(.1)		(8.0)		(8.1)
Net deferred tax benefits (income taxes)	.5		2.5		3.0		—		2.0		2.0
Other comprehensive income (loss)	(.3)		(7.2)		(7.5)		(.1)		(6.0)		(6.1)
Balances at end of period	$	(43.9)	$	13.4	$	(30.5)	$	(47.0)	$	(2.1)	$	(49.1)

XML

INFORMATION ABOUT RECEIVABLES, REVENUES, AND SERVICES. (Investment Advisory Services) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Revenue and Services [Line Items]
Net revenues	$ 1,826.8	$ 1,462.6
Average assets under management	1,508,800.0	1,162,700.0
Period end assets under management	1,518,000.0		$ 1,470,500.0
U.S. mutual funds
Revenue and Services [Line Items]
Net revenues	1,158.0	981.3
Average assets under management	814,500.0	654,300.0
Period end assets under management	816,400.0		794,600.0
U.S. mutual funds | Equity
Revenue and Services [Line Items]
Average assets under management	509,600.0	388,300.0
Period end assets under management	511,700.0		498,600.0
U.S. mutual funds | Fixed income, including money market
Revenue and Services [Line Items]
Average assets under management	82,300.0	75,700.0
Period end assets under management	82,600.0		79,400.0
U.S. mutual funds | Multi-asset
Revenue and Services [Line Items]
Average assets under management	222,600.0	190,300.0
Period end assets under management	222,100.0		216,600.0
Subadvised funds, separate accounts, collective investment trusts, and other investment products
Revenue and Services [Line Items]
Net revenues	637.6	451.6
Average assets under management	694,300.0	508,400.0
Period end assets under management	701,600.0		675,900.0
Subadvised funds, separate accounts, collective investment trusts, and other investment products | Equity
Revenue and Services [Line Items]
Average assets under management	418,900.0	277,500.0
Period end assets under management	405,500.0		397,200.0
Subadvised funds, separate accounts, collective investment trusts, and other investment products | Fixed income, including money market
Revenue and Services [Line Items]
Average assets under management	80,200.0	81,300.0
Period end assets under management	90,200.0		89,300.0
Subadvised funds, separate accounts, collective investment trusts, and other investment products | Multi-asset
Revenue and Services [Line Items]
Average assets under management	195,200.0	149,600.0
Period end assets under management	205,900.0		$ 189,400.0
Other clients
Revenue and Services [Line Items]
Net revenues	31.2	29.7
Investment advisory fees
Revenue and Services [Line Items]
Net revenues	1,687.8	1,327.8
Investment advisory fees | U.S. mutual funds
Revenue and Services [Line Items]
Net revenues	1,050.2	876.2
Investment advisory fees | U.S. mutual funds | Equity
Revenue and Services [Line Items]
Net revenues	729.8	568.4
Investment advisory fees | U.S. mutual funds | Fixed income, including money market
Revenue and Services [Line Items]
Net revenues	59.0	71.7
Investment advisory fees | U.S. mutual funds | Multi-asset
Revenue and Services [Line Items]
Net revenues	261.4	236.1
Investment advisory fees | Subadvised funds, separate accounts, collective investment trusts, and other investment products
Revenue and Services [Line Items]
Net revenues	637.6	451.6
Investment advisory fees | Subadvised funds, separate accounts, collective investment trusts, and other investment products | Equity
Revenue and Services [Line Items]
Net revenues	429.8	279.5
Investment advisory fees | Subadvised funds, separate accounts, collective investment trusts, and other investment products | Fixed income, including money market
Revenue and Services [Line Items]
Net revenues	31.7	38.0
Investment advisory fees | Subadvised funds, separate accounts, collective investment trusts, and other investment products | Multi-asset
Revenue and Services [Line Items]
Net revenues	176.1	134.1
Investment advisory fees | Other clients
Revenue and Services [Line Items]
Net revenues	0.0	0.0
Administrative fees
Revenue and Services [Line Items]
Net revenues	109.9	106.9
Administrative fees | U.S. mutual funds
Revenue and Services [Line Items]
Net revenues	78.7	77.2
Administrative fees | Subadvised funds, separate accounts, collective investment trusts, and other investment products
Revenue and Services [Line Items]
Net revenues	0.0	0.0
Administrative fees | Other clients
Revenue and Services [Line Items]
Net revenues	31.2	29.7
Distribution and servicing fees
Revenue and Services [Line Items]
Net revenues	29.1	27.9
Distribution and servicing fees | U.S. mutual funds
Revenue and Services [Line Items]
Net revenues	29.1	27.9
Distribution and servicing fees | Subadvised funds, separate accounts, collective investment trusts, and other investment products
Revenue and Services [Line Items]
Net revenues	0.0	0.0
Distribution and servicing fees | Other clients
Revenue and Services [Line Items]
Net revenues	$ 0.0	$ 0.0

XML

INFORMATION ABOUT RECEIVABLES, REVENUES, AND SERVICES. (Services Concentration and Receivables) (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Concentration Risk [Line Items]
Net revenues	$ 1,826.8	$ 1,462.6
Accounts receivable	885.9		$ 863.1
T. Rowe Price investment products
Concentration Risk [Line Items]
Net revenues	1,482.3	$ 1,207.7
Accounts receivable	$ 540.0		$ 523.4
Outside U.S. | Assets under management | Investment advisory clients | Geographic concentration
Concentration Risk [Line Items]
Concentration risk, percentage	8.80%		9.30%

XML

INVESTMENTS. (Investments) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Schedule of Equity Method Investments [Line Items]
U.S. Treasury note	$ 1.0		$ 1.0
Total	3,403.6		3,250.8
Net unrealized gains (losses) on T. Rowe Price investments product recognized in nonoperating income	38.8	$ (103.6)
Gains recognized upon deconsolidation	102.1	(500.3)
Reclassification out of accumulated other comprehensive income | Currency translation adjustments
Schedule of Equity Method Investments [Line Items]
Gains recognized upon deconsolidation	2.6	0.1
Assets
Schedule of Equity Method Investments [Line Items]
Net increase (decrease) in assets, liabilities, and redeemable noncontrolling interest	(928.1)	(46.2)
Liability
Schedule of Equity Method Investments [Line Items]
Net increase (decrease) in assets, liabilities, and redeemable noncontrolling interest	(15.3)	(2.4)
Redeemable noncontrolling interest
Schedule of Equity Method Investments [Line Items]
Net increase (decrease) in assets, liabilities, and redeemable noncontrolling interest	(739.9)	$ (20.1)
Discretionary investments
Schedule of Equity Method Investments [Line Items]
Investments held at fair value	1,664.3		1,647.7
Equity method investments	245.8		242.9
Seed capital
Schedule of Equity Method Investments [Line Items]
Investments held at fair value	269.5		169.5
Equity method investments	203.7		178.6
Supplemental savings plan liability economic hedges
Schedule of Equity Method Investments [Line Items]
Investments held at fair value	766.9		768.1
Investment partnerships and other investments
Schedule of Equity Method Investments [Line Items]
Investments held at fair value	100.6		95.1
23% investment in UTI Asset Management Company Limited (India)
Schedule of Equity Method Investments [Line Items]
Equity method investments	$ 149.1		$ 145.5
Equity method investment (ownership percentage)	23.00%		23.00%
Investment partnerships and other investments
Schedule of Equity Method Investments [Line Items]
Equity method investments	$ 2.7		$ 2.4

XML

INVESTMENTS. (Variable Interest Entities) (Details) - Variable interest entity, not primary beneficiary - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Variable Interest Entity [Line Items]
Investment carrying values	$ 289.6	$ 144.7
Unfunded capital commitments	11.3	12.3
Accounts receivable	60.7	13.8
Maximum risk of loss related to nonconsolidated variable interest entities	$ 361.6	$ 170.8

XML

FAIR VALUE MEASUREMENTS. (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020	Mar. 31, 2020
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	$ 5,173.5		$ 4,504.0
Level 1 | Fair value, measurements, recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents held in money market funds	2,487.5	$ 1,931.1
Other investments	0.2	0.5
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	15.6		$ 13.5
Level 2 | Fair value, measurements, recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other investments	0.7	0.6
Fair value measured at NAV
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
T. Rowe Price investment products and other investments	99.7	94.0
Discretionary investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
T. Rowe Price investment products and other investments	1,664.3	1,647.7
Discretionary investments | Level 1 | Fair value, measurements, recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
T. Rowe Price investment products and other investments	1,664.3	1,647.7
Seed capital
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
T. Rowe Price investment products and other investments	269.5	169.5
Seed capital | Level 1 | Fair value, measurements, recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
T. Rowe Price investment products and other investments	254.6	156.6
Seed capital | Level 2 | Fair value, measurements, recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
T. Rowe Price investment products and other investments	14.9	12.9
Supplemental savings plan liability economic hedges
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
T. Rowe Price investment products and other investments	766.9	768.1
Supplemental savings plan liability economic hedges | Level 1 | Fair value, measurements, recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
T. Rowe Price investment products and other investments	$ 766.9	$ 768.1

XML

CONSOLIDATED T. ROWE PRICE INVESTMENT PRODUCTS. (Net Assets) (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020	Mar. 31, 2020	Dec. 31, 2019
Condensed Balance Sheet Statements, Captions [Line Items]
Cash and cash equivalents	$ 2,830.1	$ 2,151.7
Investments	3,403.6	3,250.8
Other assets	218.2	219.2
Total assets	10,764.4	10,659.0
Liabilities	1,743.3	1,390.3
Attributable to redeemable non-controlling interests	1,012.9	1,561.7	$ 971.0	$ 1,121.0
Consolidated T. Rowe Price investment products
Condensed Balance Sheet Statements, Captions [Line Items]
Net assets	1,893.1	2,637.8
Attributable to T. Rowe Price Group	880.2	1,076.1
Attributable to redeemable non-controlling interests	1,012.9	1,561.7
Voting interest entities
Condensed Balance Sheet Statements, Captions [Line Items]
Net assets	159.2	188.1
Attributable to T. Rowe Price Group	96.4	130.7
Attributable to redeemable non-controlling interests	62.8	57.4
Variable interest entities
Condensed Balance Sheet Statements, Captions [Line Items]
Net assets	1,733.9	2,449.7
Attributable to T. Rowe Price Group	783.8	945.4
Attributable to redeemable non-controlling interests	950.1	1,504.3
Reportable entities | Consolidated T. Rowe Price investment products
Condensed Balance Sheet Statements, Captions [Line Items]
Cash and cash equivalents	83.7	104.8
Investments	1,822.0	2,560.9
Other assets	41.1	29.8
Total assets	1,946.8	2,695.5
Liabilities	53.7	57.7
Net assets	1,893.1	2,637.8
Reportable entities | Voting interest entities
Condensed Balance Sheet Statements, Captions [Line Items]
Cash and cash equivalents	3.0	7.1
Investments	157.5	188.2
Other assets	3.4	2.8
Total assets	163.9	198.1
Liabilities	4.7	10.0
Net assets	159.2	188.1
Reportable entities | Variable interest entities
Condensed Balance Sheet Statements, Captions [Line Items]
Cash and cash equivalents	80.7	97.7
Investments	1,664.5	2,372.7
Other assets	37.7	27.0
Total assets	1,782.9	2,497.4
Liabilities	49.0	47.7
Net assets	1,733.9	2,449.7
Reportable entities | T. Rowe Price investment products | Consolidated T. Rowe Price investment products
Condensed Balance Sheet Statements, Captions [Line Items]
Investments	24.4	26.9
Money Market Funds | Reportable entities | T. Rowe Price investment products | Consolidated T. Rowe Price investment products
Condensed Balance Sheet Statements, Captions [Line Items]
Cash and cash equivalents	$ 2.8	$ 7.0

XML

CONSOLIDATED T. ROWE PRICE INVESTMENT PRODUCTS. (Operating Results) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Condensed Income Statements, Captions [Line Items]
Operating expenses reflected in net operating income	$ (933.6)	$ (755.4)
Income before income taxes	995.3	206.9
Net income (loss) attributable to redeemable non-controlling interests	15.4	(176.5)
Consolidated T. Rowe Price investment products
Condensed Income Statements, Captions [Line Items]
Income before income taxes	33.7	(334.0)
Net income (loss) attributable to T. Rowe Price Group	18.3	(157.5)
Net income (loss) attributable to redeemable non-controlling interests	15.4	(176.5)
Voting interest entities
Condensed Income Statements, Captions [Line Items]
Income before income taxes	5.9	(35.4)
Net income (loss) attributable to T. Rowe Price Group	4.0	(22.6)
Net income (loss) attributable to redeemable non-controlling interests	1.9	(12.8)
Variable interest entities
Condensed Income Statements, Captions [Line Items]
Income before income taxes	27.8	(298.6)
Net income (loss) attributable to T. Rowe Price Group	14.3	(134.9)
Net income (loss) attributable to redeemable non-controlling interests	13.5	(163.7)
Reportable entities | Consolidated T. Rowe Price investment products
Condensed Income Statements, Captions [Line Items]
Operating expenses reflected in net operating income	(3.5)	(3.7)
Net investment income (loss) reflected in non-operating income (loss)	37.2	(330.3)
Income before income taxes	33.7	(334.0)
Reportable entities | Voting interest entities
Condensed Income Statements, Captions [Line Items]
Operating expenses reflected in net operating income	(0.2)	(0.2)
Net investment income (loss) reflected in non-operating income (loss)	6.1	(35.2)
Income before income taxes	5.9	(35.4)
Reportable entities | Variable interest entities
Condensed Income Statements, Captions [Line Items]
Operating expenses reflected in net operating income	(3.3)	(3.5)
Net investment income (loss) reflected in non-operating income (loss)	31.1	(295.1)
Income before income taxes	27.8	(298.6)
Consolidation eliminations
Condensed Income Statements, Captions [Line Items]
Operating expenses reflected in net operating income	$ (1.3)	$ (2.5)

XML

CONSOLIDATED T. ROWE PRICE INVESTMENT PRODUCTS. (Statement of Cash Flows) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Condensed Cash Flow Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	$ 994.7	$ 787.7
Net cash used in investing activities	(30.8)	27.6
Net cash provided by financing activities	(307.5)	(992.3)
Effect of exchange rate changes on cash and cash equivalents of consolidated T. Rowe Price investment products	0.9	(1.2)
Net change in cash and cash equivalents during period	657.3	(178.2)
Cash and cash equivalents at beginning of period	2,256.5	1,858.3
Cash and cash equivalents at ending of period	2,913.8	1,680.1
Consolidated T. Rowe Price investment products
Condensed Cash Flow Statements, Captions [Line Items]
Cash and cash equivalents at beginning of period	104.8	76.5
Cash and cash equivalents at ending of period	83.7	117.7
Reportable entities | Consolidated T. Rowe Price investment products
Condensed Cash Flow Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	(143.7)	(75.7)
Net cash used in investing activities	(27.3)	(0.8)
Net cash provided by financing activities	149.0	118.9
Effect of exchange rate changes on cash and cash equivalents of consolidated T. Rowe Price investment products	0.9	(1.2)
Net change in cash and cash equivalents during period	(21.1)	41.2
Cash and cash equivalents at beginning of period	104.8	76.5
Cash and cash equivalents at ending of period	83.7	117.7
Reportable entities | Voting interest entities
Condensed Cash Flow Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	(31.7)	11.3
Net cash used in investing activities	(9.1)	(0.8)
Net cash provided by financing activities	36.7	2.7
Effect of exchange rate changes on cash and cash equivalents of consolidated T. Rowe Price investment products	0.0	0.0
Net change in cash and cash equivalents during period	(4.1)	13.2
Cash and cash equivalents at beginning of period	7.1	9.9
Cash and cash equivalents at ending of period	3.0	23.1
Reportable entities | Variable interest entities
Condensed Cash Flow Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	(112.0)	(87.0)
Net cash used in investing activities	(18.2)	0.0
Net cash provided by financing activities	112.3	116.2
Effect of exchange rate changes on cash and cash equivalents of consolidated T. Rowe Price investment products	0.9	(1.2)
Net change in cash and cash equivalents during period	(17.0)	28.0
Cash and cash equivalents at beginning of period	97.7	66.6
Cash and cash equivalents at ending of period	80.7	94.6
Consolidation eliminations | Consolidated T. Rowe Price investment products
Condensed Cash Flow Statements, Captions [Line Items]
Subscriptions payment, net of dividends received	$ 34.1	$ (42.8)

XML

CONSOLIDATED T. ROWE PRICE INVESTMENT PRODUCTS. (Fair Value Measurements) (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020	Mar. 31, 2020
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	$ 5,173.5		$ 4,504.0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	15.6		$ 13.5
Fair value, measurements, recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	2,487.5	$ 1,931.1
Other investments	0.2	0.5
Fair value, measurements, recurring | Level 1 | Consolidated T. Rowe Price investment products
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	2.8	7.0
Equity securities	225.7	308.0
Fixed income securities	0.0	0.0
Other investments	4.0	2.6
Total	232.5	317.6
Liabilities	(0.4)	(0.4)
Fair value, measurements, recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other investments	0.7	0.6
Fair value, measurements, recurring | Level 2 | Consolidated T. Rowe Price investment products
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0.0	0.0
Equity securities	449.9	708.0
Fixed income securities	1,107.2	1,411.3
Other investments	35.2	131.0
Total	1,592.3	2,250.3
Liabilities	$ (9.9)	$ (18.8)

XML

STOCKHOLDERS' EQUITY. (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Stockholders' Equity Note [Abstract]
Unsettled common stock repurchases liability	$ 10.9	$ 2.5

XML

STOCK-BASED COMPENSATION. (Stock Options) (Details)	3 Months Ended
	Mar. 31, 2021 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding, beginning balance (in shares) | shares	4,329,056
Exercised (in shares) | shares	(748,203)
Outstanding, ending balance (in shares) | shares	3,580,853
Exercisable at current period-end (in shares) | shares	3,580,853
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted-average exercise price of options outstanding, beginning balance (in dollars per share) | $ / shares	$ 72.52
Weighted-average exercise price of options exercised (in dollars per share) | $ / shares	72.28
Weighted-average exercise price of options outstanding, ending balance (in dollars per share) | $ / shares	72.57
Weighted-average exercise price of options exercisable at current period-end (in dollars per share) | $ / shares	$ 72.57

XML

STOCK-BASED COMPENSATION. (Restricted Shares and Stock Units) (Details)	3 Months Ended
	Mar. 31, 2021 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted-average fair value of nonvested restricted shares and restricted stock units, beginning balance (in dollars per share) | $ / shares	$ 116.51
Weighted-average fair value of restricted shares and restricted stock units granted (in dollars per share) | $ / shares	154.03
Weighted-average fair value of restricted shares and restricted stock units nonvested dividend equivalents granted to non-employee directors (in dollars per share) | $ / shares	172.22
Weighted-average fair value of restricted shares and restricted stock units vested (in dollars per share) | $ / shares	97.37
Weighted-average fair value of restricted shares and restricted stock units forfeited (in dollars per share) | $ / shares	114.66
Weighted-average fair value of nonvested restricted shares and restricted stock units, ending balance (in dollars per share) | $ / shares	$ 116.73
Restricted shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Nonvested, beginning balance (in shares)	7,412
Grants (in shares)	0
Nonvested dividend equivalents granted to non-employee directors (in shares)	0
Vested (in shares)	0
Forfeited (in shares)	0
Nonvested, ending balance (in shares)	7,412
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Nonvested, beginning balance (in shares)	6,367,059
Grants (in shares)	3,397
Nonvested dividend equivalents granted to non-employee directors (in shares)	550
Vested (in shares)	(64,942)
Forfeited (in shares)	(19,489)
Nonvested, ending balance (in shares)	6,286,575
Restricted stock units | Performance-based
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Nonvested, ending balance (in shares)	361,609
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Nonvested shares where performance threshold has been met (in shares)	198,205

XML

STOCK-BASED COMPENSATION. (Future Stock-Based Compensation Expense) (Details) $ in Millions	Mar. 31, 2021 USD ($)
Share-based Payment Arrangement [Abstract]
Second quarter 2021	$ 56.9
Third quarter 2021	56.7
Fourth quarter 2021	50.2
2022	117.4
2023 through 2026	97.2
Total	$ 378.4

XML

EARNINGS PER SHARE CALCULATIONS. (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Earnings Per Share [Abstract]
Stock options with anti-diluted impact (in shares)	0	0
Net income attributable to T. Rowe Price Group	$ 749.4	$ 343.1
Less: net income allocated to outstanding restricted stock and stock unit holders (basic)	19.9	9.4
Less: net income allocated to outstanding restricted stock and stock unit holders (diluted)	19.9	9.4
Net income allocated to common stockholders (basic)	729.5	333.7
Net income allocated to common stockholders (diluted)	$ 729.5	$ 333.7
Weighted-average common shares
Outstanding (in shares)	227,700,000	234,100,000
Outstanding assuming dilution (in shares)	230,000,000.0	236,800,000

XML

OTHER COMPREHENSIVE INCOME AND ACCUMULATED OTHER COMPREHENSIVE LOSS. (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balances at beginning of period	$ 7,707.0	$ 7,102.1
Other comprehensive income (loss)	(7.5)	(6.1)
Balances at end of period	8,008.2	6,434.0
Other comprehensive loss, net of tax, attributable to redeemable non-controlling interests	(11.8)	(17.2)
Currency translation adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balances at beginning of period	(23.0)	(43.0)
Other comprehensive income (loss) before reclassifications and income taxes	(7.9)	(8.0)
Reclassification adjustments recognized in non-operating income	(2.6)	(0.1)
Other comprehensive income (loss), before taxes	(10.5)	(8.1)
Net deferred tax benefits (income taxes)	3.0	2.0
Other comprehensive income (loss)	(7.5)	(6.1)
Balances at end of period	(30.5)	(49.1)
Currency translation adjustments | Equity method investments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balances at beginning of period	(43.6)	(46.9)
Other comprehensive income (loss) before reclassifications and income taxes	(0.8)	(0.1)
Reclassification adjustments recognized in non-operating income	0.0	0.0
Other comprehensive income (loss), before taxes	(0.8)	(0.1)
Net deferred tax benefits (income taxes)	0.5	0.0
Other comprehensive income (loss)	(0.3)	(0.1)
Balances at end of period	(43.9)	(47.0)
Currency translation adjustments | Variable interest entities
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balances at beginning of period	20.6	3.9
Other comprehensive income (loss) before reclassifications and income taxes	(7.1)	(7.9)
Reclassification adjustments recognized in non-operating income	(2.6)	(0.1)
Other comprehensive income (loss), before taxes	(9.7)	(8.0)
Net deferred tax benefits (income taxes)	2.5	2.0
Other comprehensive income (loss)	(7.2)	(6.0)
Balances at end of period	$ 13.4	$ (2.1)